The	O
Epstein-Barr	B-protein
virus	I-protein
nuclear	I-protein
antigen	I-protein
2	I-protein
interacts	O
with	O
an	O
EBNA2	B-DNA
responsive	I-DNA
cis-element	I-DNA
of	O
the	O
terminal	B-DNA
protein	I-DNA
1	I-DNA
gene	I-DNA
promoter	I-DNA
.	O

The	O
Epstein-Barr	B-protein
virus	I-protein
protein	I-protein
EBNA2	I-protein
acts	O
as	O
a	O
transcriptional	B-protein
activator	I-protein
of	O
cellular	B-DNA
and	I-DNA
viral	I-DNA
genes	I-DNA
and	O
plays	O
a	O
crucial	O
role	O
in	O
the	O
immortalization	O
of	O
human	B-cell_type
primary	I-cell_type
B-cells	I-cell_type
by	O
EBV	O
.	O

We	O
have	O
shown	O
previously	O
that	O
EBNA2	B-protein
transactivates	O
the	O
promoters	O
of	O
the	O
latent	B-protein
membrane	I-protein
antigens	I-protein
LMP	B-protein
,	O
TP1	B-protein
and	O
TP2	B-protein
.	O

The	O
promoter	B-DNA
of	O
the	O
TP1	B-DNA
gene	I-DNA
was	O
chosen	O
as	O
a	O
model	O
system	O
to	O
study	O
the	O
molecular	O
mechanism	O
of	O
EBNA2	B-protein
mediated	O
transactivation	O
.	O

To	O
identify	O
an	O
EBNA2	B-DNA
dependent	I-DNA
cis-acting	I-DNA
element	I-DNA
,	O
various	O
TP1	B-DNA
promoter-reporter	I-DNA
gene	I-DNA
constructs	I-DNA
were	O
transfected	O
in	O
the	O
absence	O
and	O
presence	O
of	O
an	O
EBNA2	B-DNA
expression	I-DNA
vector	I-DNA
into	O
the	O
established	O
B-cell	B-cell_line
line	I-cell_line
BL41-P3HR1	I-cell_line
.	O

We	O
were	O
able	O
to	O
delineate	O
an	O
81	B-DNA
bp	I-DNA
EBNA2	I-DNA
responsive	I-DNA
region	I-DNA
between	O
-258	O
and	O
-177	O
relative	O
to	O
the	O
TP1	B-DNA
RNA	I-DNA
start	I-DNA
site	I-DNA
.	O

The	O
element	O
worked	O
in	O
either	O
orientation	O
and	O
could	O
mediate	O
EBNA2	B-protein
dependent	O
transactivation	O
on	O
a	O
heterologous	B-DNA
promoter	I-DNA
.	O

Electrophoretic	O
mobility	O
shift	O
assays	O
revealed	O
three	O
specific	O
protein-DNA	B-protein
complexes	I-protein
formed	O
with	O
sequences	O
of	O
the	O
EBNA2	B-DNA
responsive	I-DNA
element	I-DNA
.	O

Two	O
of	O
these	O
were	O
not	O
cell	O
type	O
specific	O
,	O
but	O
the	O
third	O
was	O
detected	O
only	O
in	O
EBNA2	B-protein
positive	O
cell	O
extracts	O
.	O

Gel-shift	O
analysis	O
in	O
the	O
presence	O
of	O
EBNA2	B-protein
specific	O
monoclonal	O
antibodies	O
revealed	O
that	O
EBNA2	B-protein
is	O
a	O
component	O
of	O
the	O
third	O
complex	O
.	O

Thus	O
,	O
these	O
experiments	O
demonstrate	O
that	O
EBNA2	B-protein
interacts	O
with	O
an	O
EBNA2	B-DNA
responsive	I-DNA
cis-element	I-DNA
of	O
the	O
TP1	B-DNA
promoter	I-DNA

The	NULL
EMBO	NULL
Journal	NULL
vol.12	NULL
no.1	NULL
pp.167-175	NULL
,	NULL
1993	NULL
The	NULL
Epstein-Barr	NULL
virus	NULL
nuclear	NULL
antigen	NULL
2	NULL
interacts	NULL
with	NULL
an	NULL
EBNA2	NULL
responsive	NULL
cis-element	NULL
of	NULL
the	NULL
terminal	NULL
protein	NULL
1	NULL
gene	NULL
promoter	NULL
Ursula	NULL
Zimber-Strobl	NULL
,	NULL
Elisabeth	NULL
Kremmer	NULL
'	NULL
,	NULL
Friedrich	NULL
Grasser	NULL
?	NULL

,	NULL
Gabriele	NULL
Marschall	NULL
,	NULL
Gerhard	NULL
Laux	NULL
and	NULL
Georg	NULL
W.Bornkamm	NULL
Institut	NULL
fir	NULL
Klinische	NULL
Molekularbiologie	NULL
und	NULL
Tumorgenetik	NULL
,	NULL
UInstitut	NULL
fir	NULL
Immunologie	NULL
,	NULL
im	NULL
Forschungszentrum	NULL
fiir	NULL
Umwelt	NULL
und	NULL
Gesundheit	NULL
,	NULL
GSF	NULL
,	NULL
Marchioninistrasse	NULL
25	NULL
,	NULL
8000	NULL
Miinchen	NULL
and	NULL
Institut	NULL
fiir	NULL
Medizinische	NULL
Mikrobiologie	NULL
,	NULL
Universititsklinikum	NULL
,	NULL
Haus	NULL
47	NULL
,	NULL
6650	NULL
Homburg/Saar	NULL
,	NULL
Germany	NULL
Communicated	NULL
by	NULL
W.	NULL
Schaffner	NULL
The	NULL
Epstein-Barr	NULL
virus	NULL
protein	NULL
EBNAZ	NULL
acts	NULL
as	NULL
a	NULL
transcriptional	NULL
activator	NULL
of	NULL
cellular	NULL
and	NULL
viral	NULL
genes	NULL
and	NULL
plays	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
the	NULL
immortalization	NULL
of	NULL
human	NULL
primary	NULL
B-cells	NULL
by	NULL
EBV	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
previously	NULL
that	NULL
EBNA2	NULL
transactivates	NULL
the	NULL
promoters	NULL
of	NULL
the	NULL
latent	NULL
membrane	NULL
antigens	NULL
LMP	NULL
,	NULL
TP1	NULL
and	NULL
TP2	NULL
.	NULL

The	NULL
promoter	NULL
of	NULL
the	NULL
TP	NULL
!	NULL

gene	NULL
was	NULL
chosen	NULL
as	NULL
a	NULL
model	NULL
system	NULL
to	NULL
study	NULL
the	NULL
molecular	NULL
mechanism	NULL
of	NULL
EBNA2	NULL
mediated	NULL
transactivation	NULL
.	NULL

To	NULL
identify	NULL
an	NULL
EBNA2	NULL
dependent	NULL
cis-acting	NULL
element	NULL
,	NULL
various	NULL
TPZ	NULL
promoter-reporter	NULL
gene	NULL
constructs	NULL
were	NULL
transfected	NULL
in	NULL
the	NULL
absence	NULL
and	NULL
presence	NULL
of	NULL
an	NULL
EBNA2Z	NULL
expression	NULL
vector	NULL
into	NULL
the	NULL
established	NULL
B-cell	NULL
line	NULL
BL41-P3HR1	NULL
.	NULL

We	NULL
were	NULL
able	NULL
to	NULL
delineate	NULL
an	NULL
81	NULL
bp	NULL
EBNA2	NULL
responsive	NULL
region	NULL
between	NULL
-258	NULL
and	NULL
-177	NULL
relative	NULL
to	NULL
the	NULL
TPZ	NULL
RNA	NULL
start	NULL
site	NULL
.	NULL

The	NULL
element	NULL
worked	NULL
in	NULL
either	NULL
orientation	NULL
and	NULL
could	NULL
mediate	NULL
EBNA2	NULL
dependent	NULL
transactivation	NULL
on	NULL
a	NULL
heterologous	NULL
promoter	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
revealed	NULL
three	NULL
specific	NULL
protein-DNA	NULL
complexes	NULL
formed	NULL
with	NULL
sequences	NULL
of	NULL
the	NULL
EBNA2	NULL
responsive	NULL
element	NULL
.	NULL

Two	NULL
of	NULL
these	NULL
were	NULL
not	NULL
cell	NULL
type	NULL
specific	NULL
,	NULL
but	NULL
the	NULL
third	NULL
was	NULL
detected	NULL
only	NULL
in	NULL
EBNA2	NULL
positive	NULL
cell	NULL
extracts	NULL
.	NULL

Gel-shift	NULL
analysis	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
EBNA2	NULL
specific	NULL
monoclonal	NULL
antibodies	NULL
revealed	NULL
that	NULL
EBNA2	NULL
is	NULL
a	NULL
component	NULL
of	NULL
the	NULL
third	NULL
complex	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
experiments	NULL
demonstrate	NULL
that	NULL
EBNA2	NULL
interacts	NULL
with	NULL
an	NULL
EBNA2	NULL
responsive	NULL
cis-element	NULL
of	NULL
the	NULL
TP	NULL
!	NULL

promoter	NULL
.	NULL

Key	NULL
words	NULL
:	NULL
DNA-protein	NULL
interaction/EBNA2/Epstein-Barr	NULL
virus/terminal	NULL
protein	NULL
1/transactivation	NULL
Introduction	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
,	NULL
a	NULL
widespread	NULL
human	NULL
herpesvirus	NULL
,	NULL
is	NULL
the	NULL
aetiological	NULL
agent	NULL
of	NULL
infectious	NULL
mononucleosis	NULL
,	NULL
a	NULL
self-limiting	NULL
lymphoproliferative	NULL
disease	NULL
.	NULL

The	NULL
virus	NULL
is	NULL
associated	NULL
with	NULL
two	NULL
human	NULL
malignancies	NULL
,	NULL
namely	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
(	NULL
a	NULL
B-cell	NULL
neoplasia	NULL
)	NULL
and	NULL
nasopharyngeal	NULL
carcinoma	NULL
,	NULL
which	NULL
is	NULL
composed	NULL
of	NULL
poorly	NULL
differentiated	NULL
epithelial	NULL
cells	NULL
.	NULL

EBV	NULL
has	NULL
a	NULL
dual	NULL
tropism	NULL
:	NULL
it	NULL
infects	NULL
primary	NULL
resting	NULL
B-cells	NULL
and	NULL
epithelial	NULL
cells	NULL
.	NULL

Virus	NULL
production	NULL
occurs	NULL
only	NULL
in	NULL
epithelial	NULL
cells	NULL
,	NULL
whereas	NULL
B-cells	NULL
are	NULL
latently	NULL
infected	NULL
.	NULL

In	NULL
vitro	NULL
infection	NULL
of	NULL
resting	NULL
B-lymphocytes	NULL
leads	NULL
to	NULL
the	NULL
outgrowth	NULL
of	NULL
permanently	NULL
virus	NULL
©	NULL
Oxford	NULL
University	NULL
Press	NULL
transformed	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
.	NULL

In	NULL
these	NULL
immortalized	NULL
cell	NULL
lines	NULL
the	NULL
virus	NULL
is	NULL
maintained	NULL
as	NULL
an	NULL
episomal	NULL
molecule	NULL
at	NULL
high	NULL
copy	NULL
number	NULL
(	NULL
Lindahl	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1976	NULL
)	NULL
and	NULL
only	NULL
a	NULL
few	NULL
viral	NULL
genes	NULL
are	NULL
expressed	NULL
.	NULL

These	NULL
genes	NULL
code	NULL
for	NULL
six	NULL
nuclear	NULL
antigens	NULL
,	NULL
EBNA1I	NULL
,	NULL
2	NULL
,	NULL
3a	NULL
,	NULL
3b	NULL
,	NULL
3¢c	NULL
and	NULL
-LP	NULL
,	NULL
and	NULL
three	NULL
membrane	NULL
proteins	NULL
,	NULL
the	NULL
latent	NULL
membrane	NULL
protein	NULL
(	NULL
LMP	NULL
)	NULL
and	NULL
terminal	NULL
proteins	NULL
(	NULL
TPs	NULL
)	NULL
1	NULL
and	NULL
2	NULL
,	NULL
also	NULL
denoted	NULL
by	NULL
LMP2A	NULL
and	NULL
B	NULL
(	NULL
for	NULL
review	NULL
see	NULL
Kieff	NULL
and	NULL
Liebowitz	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

These	NULL
gene	NULL
products	NULL
seem	NULL
to	NULL
be	NULL
important	NULL
for	NULL
induction	NULL
and	NULL
maintenance	NULL
of	NULL
B-cell	NULL
immortalization	NULL
.	NULL

However	NULL
,	NULL
the	NULL
individual	NULL
functions	NULL
of	NULL
these	NULL
gene	NULL
products	NULL
in	NULL
latent	NULL
infection	NULL
and	NULL
growth	NULL
transformation	NULL
are	NULL
only	NULL
poorly	NULL
understood	NULL
.	NULL

EBNAZ	NULL
,	NULL
one	NULL
of	NULL
the	NULL
best	NULL
studied	NULL
latent	NULL
gene	NULL
products	NULL
,	NULL
is	NULL
absolutely	NULL
necessary	NULL
for	NULL
B-cell	NULL
immortalization	NULL
.	NULL

One	NULL
viral	NULL
mutant	NULL
(	NULL
P3HR1	NULL
)	NULL
carrying	NULL
a	NULL
6.6	NULL
kb	NULL
deletion	NULL
(	NULL
Bornkamm	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1982	NULL
;	NULL
Jeang	NULL
and	NULL
Hayward	NULL
,	NULL
1983	NULL
)	NULL
that	NULL
removes	NULL
EBNAZ	NULL
and	NULL
part	NULL
of	NULL
EBNA-LP	NULL
,	NULL
has	NULL
lost	NULL
the	NULL
ability	NULL
to	NULL
transform	NULL
primary	NULL
B-cells	NULL
.	NULL

Reintroduction	NULL
of	NULL
EBNA2	NULL
into	NULL
the	NULL
P3HR1	NULL
virus	NULL
by	NULL
homologous	NULL
recombination	NULL
reconstituted	NULL
the	NULL
full	NULL
transforming	NULL
capacity	NULL
(	NULL
Cohen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Hammerschmidt	NULL
and	NULL
Sudgen	NULL
,	NULL
1989	NULL
)	NULL
.	NULL

In	NULL
natural	NULL
EBV	NULL
isolates	NULL
,	NULL
two	NULL
alleles	NULL
of	NULL
the	NULL
EBNAZ	NULL
gene	NULL
exist	NULL
coding	NULL
for	NULL
two	NULL
proteins	NULL
(	NULL
EBNAZA	NULL
and	NULL
EBNA2B	NULL
)	NULL
with	NULL
57	NULL
%	NULL
homology	NULL
(	NULL
Dambaugh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1984	NULL
;	NULL
Adldinger	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Zimber	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
.	NULL

There	NULL
have	NULL
been	NULL
some	NULL
reports	NULL
that	NULL
EBV	NULL
strains	NULL
carrying	NULL
EBNA2A	NULL
could	NULL
transform	NULL
primary	NULL
B-cells	NULL
more	NULL
efficiently	NULL
than	NULL
those	NULL
containing	NULL
an	NULL
EBNA2B	NULL
allele	NULL
(	NULL
Rickinson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Cohen	NULL
ert	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

The	NULL
EBNA2	NULL
gene	NULL
codes	NULL
for	NULL
a	NULL
487	NULL
amino	NULL
acid	NULL
phoshorylated	NULL
polypeptide	NULL
(	NULL
Grisser	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Characteristic	NULL
features	NULL
of	NULL
the	NULL
primary	NULL
structure	NULL
of	NULL
the	NULL
protein	NULL
include	NULL
a	NULL
proline	NULL
stretch	NULL
of	NULL
~40	NULL
amino	NULL
acids	NULL
near	NULL
the	NULL
N-terminus	NULL
,	NULL
a	NULL
negatively	NULL
charged	NULL
C-terminus	NULL
and	NULL
a	NULL
glycine/arginine-rich	NULL
region	NULL
.	NULL

It	NULL
has	NULL
recently	NULL
been	NULL
shown	NULL
that	NULL
EBNAZ	NULL
acts	NULL
as	NULL
a	NULL
transcriptional	NULL
activator	NULL
:	NULL
it	NULL
stimulates	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
cellular	NULL
genes	NULL
CD2	NULL
]	NULL
,	NULL
CD23	NULL
and	NULL
c-fgr	NULL
(	NULL
Calender	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Wang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Abbot	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Cordier	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Knutson	NULL
,	NULL
1990	NULL
)	NULL
as	NULL
well	NULL
as	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
viral	NULL
genes	NULL
LMP	NULL
,	NULL
TP	NULL
]	NULL
and	NULL
TP2	NULL
(	NULL
Fahraeus	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Ghosh	NULL
and	NULL
Kieff	NULL
,	NULL
1990	NULL
;	NULL
Zimber-Strobl	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Although	NULL
a	NULL
transactivation	NULL
domain	NULL
has	NULL
been	NULL
mapped	NULL
in	NULL
the	NULL
C-terminus	NULL
of	NULL
EBNA2	NULL
(	NULL
Cohen	NULL
and	NULL
Kieff	NULL
,	NULL
1991	NULL
)	NULL
,	NULL
it	NULL
is	NULL
not	NULL
yet	NULL
known	NULL
whether	NULL
EBNA2	NULL
transactivates	NULL
several	NULL
genes	NULL
by	NULL
interacting	NULL
with	NULL
EBNAZ	NULL
responsive	NULL
cis-elements	NULL
or	NULL
whether	NULL
it	NULL
does	NULL
so	NULL
by	NULL
modulating	NULL
the	NULL
expression	NULL
or	NULL
modification	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

A	NULL
consensus	NULL
sequence	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
EBNA2	NULL
?	NULL

-regulated	NULL
genes	NULL
has	NULL
not	NULL
been	NULL
described	NULL
until	NULL
now	NULL
.	NULL

To	NULL
elucidate	NULL
the	NULL
mechanism	NULL
of	NULL
EBNAZ2	NULL
mediated	NULL
transactivation	NULL
,	NULL
we	NULL
focused	NULL
our	NULL
interest	NULL
on	NULL
the	NULL
TP	NULL
]	NULL
promoter	NULL
region	NULL
.	NULL

The	NULL
7P	NULL
gene	NULL
is	NULL
transcribed	NULL
across	NULL
the	NULL
terminal	NULL
repeats	NULL
of	NULL
the	NULL
EBV	NULL
genome	NULL
(	NULL
Laux	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Sample	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

A	NULL
functional	NULL
transcription	NULL
unit	NULL
can	NULL
only	NULL
be	NULL
created	NULL
if	NULL
the	NULL
linear	NULL
molecule	NULL
is	NULL
circularized	NULL
.	NULL

The	NULL
TATA-box	NULL
of	NULL
the	NULL
TP	NULL
]	NULL
promoter	NULL
is	NULL
located	NULL
at	NULL
the	NULL
right	NULL
hand	NULL
end	NULL
of	NULL
the	NULL
linear	NULL
viral	NULL
167	NULL
U.Zimber-Strobl	NULL
et	NULL
al	NULL
.	NULL

&	NULL
P	NULL
s	NULL
&	NULL
es	NULL
3	NULL
§2	NULL
$	NULL
p	NULL
#	NULL
f	NULL
£	NULL
__¢i4	NULL
¢	NULL
¢	NULL
SICI	NULL
I	NULL
|p	NULL
___	NULL
-	NULL
45	NULL
crzeme	NULL
{	NULL
[	NULL
-_	NULL
.	NULL

=	NULL
~	NULL
___|	NULL
-177	NULL
m	NULL
:	NULL
C	NULL
-	NULL
258	NULL
B	NULL
%	NULL
acetylation	NULL
Stimulation	NULL
BL41-P3HR1/	NULL
ezz2222222r2rr22222222222207	NULL
27	NULL
1	NULL
C	NULL
-	NULL
CAT-constructs	NULL
|	NULL
BL41-P3HR1	NULL
BL41-B95-8	NULL
|	NULL
B41.995-8	NULL
C	NULL
``	NULL
432	NULL
ES	NULL
21	NULL
2.1	NULL
1	NULL
L	NULL
--	NULL
543	NULL
477	NULL
1.5	NULL
1.2	NULL
0.8	NULL
f-	NULL
L	NULL
258	NULL
1.0	NULL
105	NULL
105	NULL
--	NULL
-	NULL
>	NULL
804	NULL
432	NULL
0.7	NULL
7.2	NULL
10.4	NULL
2m	NULL
:	NULL
A	NULL
-147/-258	NULL
543	NULL
0.3	NULL
5.3	NULL
17.7	NULL
RLU	NULL
100000	NULL
:	NULL
I	NULL
h	NULL
a	NULL
P	NULL
10000	NULL
3	NULL
1000	NULL
=	NULL
f	NULL
~45	NULL
-124	NULL
~177	NULL
-~258	NULL
~432	NULL
-543	NULL
-804	NULL
_	NULL
A-147/	NULL
_	NULL
transfected	NULL
258	NULL
LUC-constructs	NULL
1,7	NULL
1,1	NULL
12	NULL
0	NULL
25,6	NULL
0	NULL
50,9	NULL
0	NULL
57,2	NULL
71	NULL
0,72	NULL
_	NULL
fold	NULL
induction	NULL
by	NULL
EBNA2Z	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Transfection	NULL
of	NULL
different	NULL
TP/	NULL
promoter-reporter	NULL
gene	NULL
constructs	NULL
in	NULL
the	NULL
absence	NULL
and	NULL
presence	NULL
of	NULL
EBNAZ	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
the	NULL
TPI	NULL
promoter-reporter	NULL
gene	NULL
constructs	NULL
.	NULL

The	NULL
restriction	NULL
enzymes	NULL
used	NULL
to	NULL
construct	NULL
the	NULL
recombinant	NULL
plasmids	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
TP/	NULL
promoter	NULL
fragments	NULL
denote	NULL
their	NULL
5'-end	NULL
relative	NULL
to	NULL
the	NULL
TP7	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

Open	NULL
boxes	NULL
represent	NULL
the	NULL
reporter	NULL
gene	NULL
,	NULL
hatched	NULL
boxes	NULL
the	NULL
TP/	NULL
promoter	NULL
region	NULL
.	NULL

(	NULL
B	NULL
)	NULL
CAT	NULL
activities	NULL
after	NULL
transfection	NULL
of	NULL
the	NULL
TPZ	NULL
promoter-CAT	NULL
constructs	NULL
into	NULL
EBNAZ	NULL
negative	NULL
BL41-P3HR1	NULL
cells	NULL
and	NULL
EBNAZ	NULL
positive	NULL
BL41-B95-8	NULL
cells	NULL
.	NULL

Median	NULL
activities	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
and	NULL
the	NULL
fold	NULL
inductions	NULL
by	NULL
EBNAZ	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Relative	NULL
light	NULL
units	NULL
(	NULL
RLU	NULL
)	NULL
measured	NULL
after	NULL
transfections	NULL
of	NULL
7P/	NULL
promoter-LUC	NULL
constructs	NULL
in	NULL
the	NULL
absence	NULL
and	NULL
presence	NULL
of	NULL
EBNA2	NULL
expression	NULL
vectors	NULL
into	NULL
BLA41-P3HR1	NULL
cells	NULL
.	NULL

Open	NULL
boxes	NULL
,	NULL
transfections	NULL
without	NULL
EBNAZ	NULL
;	NULL
hatched	NULL
boxes	NULL
,	NULL
cotransfection	NULL
with	NULL
the	NULL
EBNAZ	NULL
expression	NULL
vector	NULL
pU294-6	NULL
,	NULL
coding	NULL
for	NULL
wild-type	NULL
EBNA2	NULL
;	NULL
dotted	NULL
and	NULL
black	NULL
boxes	NULL
,	NULL
cotransfections	NULL
with	NULL
EBNAZ	NULL
expression	NULL
vectors	NULL
p604	NULL
and	NULL
pU812/9	NULL
respectively	NULL
,	NULL
coding	NULL
for	NULL
mutated	NULL
EBNAZ	NULL
.	NULL

The	NULL
median	NULL
activities	NULL
of	NULL
two	NULL
to	NULL
five	NULL
independent	NULL
experiments	NULL
and	NULL
standard	NULL
deviations	NULL
are	NULL
indicated	NULL
.	NULL

genome	NULL
at	NULL
position	NULL
166	NULL
469	NULL
of	NULL
the	NULL
B95-8	NULL
virus	NULL
DNA	NULL
sequence	NULL
(	NULL
Baer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1984	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
describe	NULL
an	NULL
element	NULL
that	NULL
mediates	NULL
transactivation	NULL
by	NULL
EBNA2	NULL
to	NULL
the	NULL
TPZ	NULL
promoter	NULL
.	NULL

In	NULL
addition	NULL
we	NULL
demonstrate	NULL
specific	NULL
protein-DNA	NULL
interactions	NULL
within	NULL
this	NULL
region	NULL
and	NULL
provide	NULL
evidence	NULL
that	NULL
EBNAZ	NULL
itself	NULL
is	NULL
a	NULL
component	NULL
of	NULL
this	NULL
protein-DNA	NULL
complex	NULL
.	NULL

168	NULL
Results	NULL
Identification	NULL
of	NULL
an	NULL
EBNAZ	NULL
responsive	NULL
cis-element	NULL
within	NULL
the	NULL
TP1	NULL
promoter	NULL
region	NULL
EBNA2	NULL
transactivated	NULL
a	NULL
TP	NULL
]	NULL
promoter-CAT	NULL
construct	NULL
containing	NULL
804	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
TPZ	NULL
cap	NULL
site	NULL
(	NULL
Zimber-Strobl	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Plasmids	NULL
containing	NULL
progressive	NULL
@	NULL
o	NULL
0	NULL
0	NULL
e	NULL
o	NULL
0	NULL
o	NULL
0	NULL
0	NULL
0	NULL
0	NULL
0	NULL
0	NULL
©	NULL
EBNAZ	NULL
interaction	NULL
with	NULL
TP	NULL
?	NULL

promoter	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

81	NULL
bp	NULL
(	NULL
-177	NULL
to	NULL
-258	NULL
)	NULL
of	NULL
the	NULL
TPZ	NULL
promoter	NULL
are	NULL
sufficient	NULL
to	NULL
mediate	NULL
transactivation	NULL
by	NULL
EBNA2	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Results	NULL
of	NULL
CAT	NULL
assays	NULL
of	NULL
transfections	NULL
of	NULL
CAT	NULL
constructs	NULL
containing	NULL
the	NULL
EBNA2	NULL
responsive	NULL
region	NULL
(	NULL
pTP1-CAT/135bp	NULL
and	NULL
pTP1-CAT/81bp	NULL
)	NULL
in	NULL
front	NULL
of	NULL
the	NULL
TPZ	NULL
minimal	NULL
promoter	NULL
(	NULL
pTP1-CAT/-45	NULL
)	NULL
without	NULL
EBNA2Z	NULL
(	NULL
-	NULL
)	NULL
,	NULL
with	NULL
pU294-6	NULL
coding	NULL
for	NULL
wild-type	NULL
EBNA2	NULL
(	NULL
WT	NULL
)	NULL
and	NULL
with	NULL
p604	NULL
coding	NULL
for	NULL
mutated	NULL
EBNA2	NULL
(	NULL
Mut	NULL
)	NULL
into	NULL
BL41-P3HR	NULL
1	NULL
cells	NULL
.	NULL

The	NULL
element	NULL
was	NULL
cloned	NULL
in	NULL
the	NULL
correct	NULL
(	NULL
135bp/1	NULL
,	NULL
$	NULL
1bp/1l	NULL
)	NULL
and	NULL
inverse	NULL
(	NULL
135bp/2	NULL
,	NULL
81bp/2	NULL
)	NULL
orientations	NULL
.	NULL

(	NULL
B	NULL
)	NULL
CAT	NULL
assays	NULL
after	NULL
transfections	NULL
of	NULL
CAT	NULL
constructs	NULL
containing	NULL
the	NULL
7P7	NULL
promoter	NULL
region	NULL
from	NULL
position	NULL
-124	NULL
to	NULL
-258	NULL
in	NULL
front	NULL
of	NULL
the	NULL
3-globin	NULL
minimal	NULL
promoter	NULL
into	NULL
BL41-P3HR1	NULL
cells	NULL
without	NULL
EBNA2	NULL
(	NULL
-	NULL
)	NULL
and	NULL
with	NULL
the	NULL
EBNAZ	NULL
expression	NULL
vector	NULL
pU294-6	NULL
(	NULL
+	NULL
)	NULL
.	NULL

The	NULL
element	NULL
is	NULL
cloned	NULL
in	NULL
either	NULL
orientation	NULL
correct	NULL
;	NULL
B135bp/2	NULL
,	NULL
inverse	NULL
)	NULL
.	NULL

truncations	NULL
of	NULL
the	NULL
5	NULL
'	NULL
region	NULL
of	NULL
the	NULL
TPZ	NULL
promoter	NULL
linked	NULL
to	NULL
the	NULL
reporter	NULL
genes	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
or	NULL
luciferase	NULL
(	NULL
LUC	NULL
)	NULL
were	NULL
constructed	NULL
(	NULL
Figure	NULL
1A	NULL
)	NULL
to	NULL
identify	NULL
an	NULL
EBNA2Z	NULL
responsive	NULL
cis-element	NULL
within	NULL
this	NULL
promoter	NULL
.	NULL

These	NULL
constructs	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
the	NULL
EBNA2	NULL
negative	NULL
BL41-P3HR	NULL
1	NULL
cell	NULL
line	NULL
and	NULL
into	NULL
EBNA2	NULL
positive	NULL
BL41-B95-8	NULL
cells	NULL
A	NULL
cytomegalovirus	NULL
enhancer-long	NULL
terminal	NULL
repeat-CAT	NULL
construct	NULL
(	NULL
CMV-LTR-CAT	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

Transfections	NULL
of	NULL
the	NULL
TP	NULL
]	NULL
promoter	NULL
-CAT	NULL
constructs	NULL
into	NULL
BL41-P3HR	NULL
1	NULL
cells	NULL
resulted	NULL
in	NULL
very	NULL
low	NULL
or	NULL
undetectable	NULL
CAT	NULL
activities	NULL
(	NULL
Figure	NULL
1B	NULL
)	NULL
.	NULL

Transfections	NULL
of	NULL
constructs	NULL
containing	NULL
-45	NULL
,	NULL
-124	NULL
and	NULL
-177	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
TP	NULL
]	NULL
cap	NULL
site	NULL
into	NULL
BL41-B95-8	NULL
cells	NULL
resulted	NULL
in	NULL
low	NULL
CAT	NULL
activities	NULL
similar	NULL
to	NULL
those	NULL
obtained	NULL
with	NULL
transfections	NULL
into	NULL
BL41-P3HR1	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
CAT	NULL
activities	NULL
significantly	NULL
increased	NULL
after	NULL
transfections	NULL
of	NULL
CAT	NULL
constructs	NULL
containing	NULL
sequences	NULL
upstream	NULL
of	NULL
position	NULL
-177	NULL
relative	NULL
to	NULL
the	NULL
TPZ	NULL
cap	NULL
site	NULL
(	NULL
Figure	NULL
1B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggested	NULL
that	NULL
an	NULL
EBNA2	NULL
responsive	NULL
region	NULL
is	NULL
located	NULL
between	NULL
-177	NULL
and	NULL
-258	NULL
.	NULL

We	NULL
performed	NULL
cotransfection	NULL
experiments	NULL
in	NULL
order	NULL
to	NULL
prove	NULL
that	NULL
the	NULL
increased	NULL
TPZ	NULL
promoter	NULL
activity	NULL
in	NULL
BL41-B95-8	NULL
cells	NULL
is	NULL
mediated	NULL
by	NULL
EBNA2Z	NULL
.	NULL

TPZ	NULL
promoter	NULL
deletion	NULL
constructs	NULL
driving	NULL
the	NULL
reporter	NULL
gene	NULL
luciferase	NULL
were	NULL
transfected	NULL
into	NULL
BL41-P3HR	NULL
1	NULL
cells	NULL
either	NULL
without	NULL
EBNA2	NULL
or	NULL
with	NULL
an	NULL
EBNA2ZA	NULL
(	NULL
pU294-6	NULL
)	NULL
expression	NULL
vector	NULL
or	NULL
with	NULL
EBNAZA	NULL
expression	NULL
vectors	NULL
carrying	NULL
mutations	NULL
within	NULL
the	NULL
EBNA2	NULL
open	NULL
reading	NULL
frame	NULL
(	NULL
ORF	NULL
)	NULL
.	NULL

The	NULL
EBNA2	NULL
mutation	NULL
p604	NULL
contains	NULL
a	NULL
linker	NULL
insertion	NULL
after	NULL
one-third	NULL
of	NULL
the	NULL
EBNA2	NULL
ORF	NULL
,	NULL
leading	NULL
to	NULL
a	NULL
truncated	NULL
EBNA2	NULL
gene	NULL
product	NULL
.	NULL

In	NULL
the	NULL
EBNA2	NULL
mutation	NULL
pU812/9	NULL
,	NULL
amino	NULL
acids	NULL
248-382	NULL
of	NULL
EBNA2	NULL
are	NULL
deleted	NULL
.	NULL

The	NULL
EBNA2	NULL
gene	NULL
and	NULL
its	NULL
mutants	NULL
are	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
natural	NULL
promoter	NULL
of	NULL
EBNA2	NULL
.	NULL

The	NULL
obtained	NULL
relative	NULL
light	NULL
units	NULL
(	NULL
RLU	NULL
)	NULL
of	NULL
the	NULL
LUC	NULL
assays	NULL
confirmed	NULL
the	NULL
CAT	NULL
data	NULL
described	NULL
above	NULL
(	NULL
Figure	NULL
1C	NULL
)	NULL
.	NULL

Only	NULL
LUC	NULL
constructs	NULL
containing	NULL
at	NULL
least	NULL
258	NULL
bp	NULL
of	NULL
the	NULL
TPZ	NULL
5	NULL
flanking	NULL
region	NULL
were	NULL
inducible	NULL
by	NULL
EBNA2	NULL
(	NULL
by	NULL
factors	NULL
of	NULL
25-71	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
three	NULL
smallest	NULL
constructs	NULL
were	NULL
unresponsive	NULL
to	NULL
EBNA2Z	NULL
.	NULL

In	NULL
order	NULL
to	NULL
demonstrate	NULL
that	NULL
a	NULL
specific	NULL
EBNA2	NULL
responsive	NULL
element	NULL
has	NULL
been	NULL
identified	NULL
,	NULL
we	NULL
removed	NULL
the	NULL
TP	NULL
]	NULL
promoter	NULL
region	NULL
between	NULL
positions	NULL
-258	NULL
and	NULL
-147	NULL
in	NULL
the	NULL
TPZ	NULL
promoter	NULL
reporter	NULL
gene	NULL
construct	NULL
pTP1-LUC/-543	NULL
,	NULL
leaving	NULL
the	NULL
boundaries	NULL
of	NULL
the	NULL
TPZ	NULL
promoter	NULL
intact	NULL
.	NULL

This	NULL
construct	NULL
was	NULL
transfected	NULL
into	NULL
BL41-P3HR	NULL
1	NULL
cells	NULL
together	NULL
with	NULL
the	NULL
EBNA2	NULL
expression	NULL
vectors	NULL
mentioned	NULL
above	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
1C	NULL
,	NULL
induction	NULL
of	NULL
LUC	NULL
activities	NULL
by	NULL
EBNA2	NULL
could	NULL
not	NULL
be	NULL
observed	NULL
after	NULL
transfection	NULL
of	NULL
the	NULL
TP	NULL
]	NULL
promoter	NULL
LUC	NULL
construct	NULL
lacking	NULL
the	NULL
TPZ	NULL
promoter	NULL
region	NULL
between	NULL
-258	NULL
and	NULL
-147	NULL
.	NULL

This	NULL
was	NULL
confirmed	NULL
by	NULL
transfection	NULL
of	NULL
the	NULL
same	NULL
construct	NULL
with	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
show	NULL
that	NULL
sequences	NULL
between	NULL
-258	NULL
and	NULL
-147	NULL
are	NULL
required	NULL
for	NULL
EBNA2	NULL
mediated	NULL
transactivation	NULL
.	NULL

The	NULL
EBNAZ	NULL
responsive	NULL
element	NULL
is	NULL
orientation	NULL
independent	NULL
and	NULL
active	NULL
on	NULL
a	NULL
heterologous	NULL
promoter	NULL
The	NULL
putative	NULL
element	NULL
was	NULL
cloned	NULL
in	NULL
front	NULL
of	NULL
the	NULL
7P7	NULL
minimal	NULL
promoter	NULL
(	NULL
+60/-45	NULL
)	NULL
and	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
to	NULL
study	NULL
whether	NULL
the	NULL
EBNA2	NULL
responsive	NULL
region	NULL
is	NULL
active	NULL
even	NULL
when	NULL
separated	NULL
from	NULL
its	NULL
cognate	NULL
7P	NULL
7	NULL
promoter	NULL
region	NULL
.	NULL

Two	NULL
DNA	NULL
constructs	NULL
were	NULL
made	NULL
carrying	NULL
a	NULL
larger	NULL
(	NULL
-	NULL
124	NULL
to	NULL
-258	NULL
)	NULL
and	NULL
a	NULL
smaller	NULL
fragment	NULL
(	NULL
-177	NULL
to	NULL
-258	NULL
)	NULL
in	NULL
both	NULL
orientations	NULL
.	NULL

In	NULL
these	NULL
constructs	NULL
the	NULL
suggested	NULL
EBNAZ	NULL
responsive	NULL
element	NULL
is	NULL
surrounded	NULL
by	NULL
vector	NULL
sequences	NULL
.	NULL

The	NULL
distance	NULL
of	NULL
the	NULL
element	NULL
from	NULL
the	NULL
TP	NULL
]	NULL
TATA	NULL
box	NULL
is	NULL
comparable	NULL
to	NULL
the	NULL
native	NULL
situation	NULL
.	NULL

All	NULL
DNA	NULL
constructs	NULL
were	NULL
transfected	NULL
in	NULL
the	NULL
absence	NULL
and	NULL
presence	NULL
of	NULL
EBNAZ	NULL
expression	NULL
vectors	NULL
into	NULL
BL41-P3HR	NULL
1	NULL
cells	NULL
.	NULL

pU294-6	NULL
and	NULL
p604	NULL
,	NULL
coding	NULL
for	NULL
wild-type	NULL
EBNAZ	NULL
and	NULL
truncated	NULL
EBNA2	NULL
,	NULL
respectively	NULL
,	NULL
were	NULL
used	NULL
as	NULL
EBNA2	NULL
expression	NULL
vectors	NULL
.	NULL

Transfection	NULL
of	NULL
all	NULL
constructs	NULL
169	NULL
U.Zimber-Strobl	NULL
et	NULL
al	NULL
.	NULL

Fig	NULL
.	NULL

3	NULL
.	NULL

Analysis	NULL
of	NULL
DNA-protein	NULL
interactions	NULL
within	NULL
the	NULL
7P/	NULL
promoter	NULL
.	NULL

Autoradiogram	NULL
of	NULL
an	NULL
EMSA	NULL
is	NULL
shown	NULL
made	NULL
with	NULL
nuclear	NULL
extracts	NULL
of	NULL
BL41-P3HR1	NULL
cells	NULL
which	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
32P-labelled	NULL
fragment	NULL
spanning	NULL
the	NULL
TPZ	NULL
promoter	NULL
region	NULL
from	NULL
position	NULL
-12	NULL
to	NULL
-258	NULL
relative	NULL
to	NULL
the	NULL
TP7	NULL
transcription	NULL
start	NULL
.	NULL

Competition	NULL
studies	NULL
were	NULL
performed	NULL
with	NULL
oligonucleotides	NULL
covering	NULL
the	NULL
EBNA2Z	NULL
responsive	NULL
region	NULL
identified	NULL
in	NULL
the	NULL
CAT	NULL
and	NULL
LUC	NULL
analyses	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
oligonucleotides	NULL
in	NULL
the	NULL
EBV	NULL
genome	NULL
are	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
methods	NULL
.	NULL

Unlabelled	NULL
oligonucleotides	NULL
were	NULL
added	NULL
to	NULL
the	NULL
gel-shift	NULL
reaction	NULL
in	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
.	NULL

resulted	NULL
in	NULL
a	NULL
significant	NULL
higher	NULL
CAT	NULL
activity	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
EBNAZ	NULL
expression	NULL
vector	NULL
pU294-6	NULL
,	NULL
regardless	NULL
of	NULL
the	NULL
orientation	NULL
of	NULL
the	NULL
element	NULL
relative	NULL
to	NULL
the	NULL
promoter	NULL
(	NULL
Figure	NULL
2A	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
EBNAZ	NULL
responsive	NULL
region	NULL
contains	NULL
sequences	NULL
that	NULL
can	NULL
regulate	NULL
a	NULL
heterologous	NULL
promoter	NULL
,	NULL
we	NULL
cloned	NULL
the	NULL
7P/	NULL
promoter	NULL
region	NULL
from	NULL
positions	NULL
-	NULL
124	NULL
to	NULL
-258	NULL
upstream	NULL
of	NULL
the	NULL
3-globin	NULL
minimal	NULL
promoter	NULL
(	NULL
Westin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
.	NULL

Cotransfections	NULL
of	NULL
the	NULL
EBNA2	NULL
expression	NULL
vector	NULL
pU294-6	NULL
resulted	NULL
in	NULL
significantly	NULL
increased	NULL
CAT	NULL
activities	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
reporter	NULL
plasmids	NULL
carrying	NULL
the	NULL
EBNA2Z	NULL
responsive	NULL
region	NULL
(	NULL
Figure	NULL
2B	NULL
)	NULL
.	NULL

In	NULL
this	NULL
assay	NULL
,	NULL
the	NULL
element	NULL
conferred	NULL
EBNA2	NULL
inducibility	NULL
in	NULL
an	NULL
orientation	NULL
independent	NULL
fashion	NULL
as	NULL
has	NULL
been	NULL
demonstrated	NULL
by	NULL
the	NULL
TP	NULL
]	NULL
promoter	NULL
constructs	NULL
.	NULL

From	NULL
these	NULL
data	NULL
we	NULL
conclude	NULL
that	NULL
an	NULL
81	NULL
bp	NULL
region	NULL
within	NULL
the	NULL
7P1	NULL
promoter	NULL
harbours	NULL
an	NULL
EBNA2Z	NULL
responsive	NULL
cis-element	NULL
,	NULL
which	NULL
we	NULL
will	NULL
call	NULL
EBNAZRE	NULL
.	NULL

EBNAZRE	NULL
is	NULL
active	NULL
in	NULL
both	NULL
orientations	NULL
and	NULL
able	NULL
to	NULL
regulate	NULL
a	NULL
heterologous	NULL
promoter	NULL
.	NULL

Specific	NULL
DNA-protein	NULL
interactions	NULL
within	NULL
the	NULL
EBNAZ	NULL
responsive	NULL
region	NULL
Gel-retardation	NULL
assays	NULL
were	NULL
performed	NULL
to	NULL
identify	NULL
specific	NULL
DNA-protein	NULL
interactions	NULL
within	NULL
the	NULL
7P7	NULL
promoter	NULL
.	NULL

A	NULL
DNA	NULL
fragment	NULL
spanning	NULL
the	NULL
TP	NULL
]	NULL
promoter	NULL
from	NULL
position	NULL
-12	NULL
to	NULL
-258	NULL
was	NULL
end-labelled	NULL
and	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
of	NULL
BL41-P3HR1	NULL
cells	NULL
.	NULL

The	NULL
result	NULL
of	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
(	NULL
EMSA	NULL
)	NULL
is	NULL
shown	NULL
in	NULL
Figure	NULL
3	NULL
.	NULL

EMSA	NULL
revealed	NULL
one	NULL
prominent	NULL
DNA-protein	NULL
interaction	NULL
(	NULL
complex	NULL
I	NULL
)	NULL
and	NULL
two	NULL
weaker	NULL
complexes	NULL
(	NULL
II	NULL
and	NULL
IID	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
some	NULL
of	NULL
these	NULL
complexes	NULL
are	NULL
formed	NULL
with	NULL
sequences	NULL
located	NULL
in	NULL
the	NULL
EBNA2	NULL
responsive	NULL
region	NULL
(	NULL
-258	NULL
170	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

EMSAs	NULL
using	NULL
O054bp	NULL
(	NULL
EBV	NULL
positions	NULL
166	NULL
236-166	NULL
289	NULL
according	NULL
to	NULL
the	NULL
EBV	NULL
sequence	NULL
of	NULL
Baer	NULL
er	NULL
al	NULL
.	NULL

,	NULL
1984	NULL
)	NULL
as	NULL
radioactively	NULL
labelled	NULL
probe	NULL
and	NULL
nuclear	NULL
extracts	NULL
of	NULL
the	NULL
promyelocyte	NULL
line	NULL
HL6O0	NULL
,	NULL
cervical	NULL
carcinoma	NULL
line	NULL
HeLa	NULL
,	NULL
the	NULL
EBV	NULL
negative	NULL
B-cell	NULL
line	NULL
BL41	NULL
and	NULL
four	NULL
EBV	NULL
positive	NULL
B-cell	NULL
lines	NULL
:	NULL
BL4I-P3HR1	NULL
(	NULL
EBNAZ	NULL
negative	NULL
)	NULL
,	NULL
HHS14	NULL
(	NULL
EBNAZ	NULL
negative	NULL
)	NULL
,	NULL
Jijoye	NULL
(	NULL
EBNA2B	NULL
)	NULL
and	NULL
M-ABA	NULL
(	NULL
EBNA2A	NULL
)	NULL
.	NULL

to	NULL
-177	NULL
)	NULL
,	NULL
four	NULL
overlapping	NULL
oligonucleotides	NULL
[	NULL
O1	NULL
(	NULL
-262/-230	NULL
)	NULL
,	NULL
02	NULL
(	NULL
-239/-209	NULL
)	NULL
,	NULL
03	NULL
(	NULL
-219/-181	NULL
)	NULL
and	NULL
(	NULL
4	NULL
(	NULL
-196/-158	NULL
)	NULL
]	NULL
covering	NULL
these	NULL
sequences	NULL
were	NULL
synthesized	NULL
and	NULL
added	NULL
to	NULL
BL41-P3HR1	NULL
extracts	NULL
.	NULL

Complexes	NULL
I	NULL
and	NULL
III	NULL
could	NULL
be	NULL
competed	NULL
with	NULL
O1	NULL
and	NULL
O2	NULL
covering	NULL
sequences	NULL
between	NULL
-262	NULL
and	NULL
-209	NULL
.	NULL

None	NULL
of	NULL
the	NULL
complexes	NULL
could	NULL
be	NULL
competed	NULL
by	NULL
the	NULL
adjacent	NULL
oligonucleotides	NULL
O3	NULL
and	NULL
O4	NULL
.	NULL

In	NULL
order	NULL
to	NULL
study	NULL
the	NULL
interaction	NULL
of	NULL
7PZ	NULL
promoter	NULL
sequences	NULL
from	NULL
position	NULL
-262	NULL
to	NULL
-209	NULL
with	NULL
cellular	NULL
proteins	NULL
in	NULL
more	NULL
detail	NULL
,	NULL
the	NULL
54	NULL
bp	NULL
fragment	NULL
was	NULL
end-labelled	NULL
and	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
of	NULL
several	NULL
cell	NULL
lines	NULL
(	NULL
HL60	NULL
,	NULL
HeLa	NULL
,	NULL
BL41	NULL
,	NULL
BL41-P3HR1	NULL
,	NULL
HH514	NULL
,	NULL
Jijoye	NULL
,	NULL
M-ABA	NULL
and	NULL
Raji	NULL
)	NULL
(	NULL
Figures	NULL
4	NULL
and	NULL
5A	NULL
)	NULL
.	NULL

Similar	NULL
complexes	NULL
were	NULL
formed	NULL
with	NULL
the	NULL
54	NULL
bp	NULL
fragment	NULL
as	NULL
with	NULL
the	NULL
247	NULL
bp	NULL
fragment	NULL
used	NULL
in	NULL
the	NULL
EMSA	NULL
described	NULL
above	NULL
.	NULL

Again	NULL
one	NULL
prominent	NULL
(	NULL
I	NULL
)	NULL
and	NULL
two	NULL
weaker	NULL
complexes	NULL
(	NULL
II	NULL
and	NULL
III	NULL
)	NULL
could	NULL
be	NULL
detected	NULL
.	NULL

Complexes	NULL
I-III	NULL
were	NULL
formed	NULL
in	NULL
all	NULL
cell	NULL
extracts	NULL
tested	NULL
and	NULL
therefore	NULL
seem	NULL
to	NULL
be	NULL
cell-type	NULL
unspecific	NULL
.	NULL

Notably	NULL
,	NULL
additional	NULL
complexes	NULL
(	NULL
IVA	NULL
and	NULL
IVB	NULL
)	NULL
could	NULL
be	NULL
detected	NULL
with	NULL
extracts	NULL
of	NULL
the	NULL
EBNA2	NULL
positive	NULL
cell	NULL
lines	NULL
Jijoye	NULL
,	NULL
M-ABA	NULL
and	NULL
Raji	NULL
,	NULL
which	NULL
were	NULL
not	NULL
found	NULL
with	NULL
extracts	NULL
of	NULL
EBNA2	NULL
negative	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
DNA-protein	NULL
interactions	NULL
was	NULL
analysed	NULL
in	NULL
competition	NULL
experiments	NULL
following	NULL
addition	NULL
of	NULL
the	NULL
unlabelled	NULL
54	NULL
bp	NULL
oligonucleotide	NULL
to	NULL
EMSAs	NULL
with	NULL
Raji	NULL
,	NULL
HH514	NULL
,	NULL
Jijoye	NULL
and	NULL
M-ABA	NULL
extracts	NULL
(	NULL
Figure	NULL
5A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Only	NULL
complex	NULL
II	NULL
could	NULL
not	NULL
be	NULL
competed	NULL
and	NULL
appears	NULL
to	NULL
be	NULL
unspecific	NULL
.	NULL

Additionally	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
ability	NULL
of	NULL
O1	NULL
and	NULL
O2	NULL
to	NULL
prevent	NULL
formation	NULL
of	NULL
protein-DNA	NULL
complexes	NULL
formed	NULL
with	NULL
the	NULL
54	NULL
bp	NULL
oligonucleotide	NULL
and	NULL
nuclear	NULL
proteins	NULL
of	NULL
Raji	NULL
cells	NULL
.	NULL

All	NULL
specific	NULL
complexes	NULL
could	NULL
be	NULL
competed	NULL
by	NULL
O1	NULL
and	NULL
O2	NULL
with	NULL
the	NULL
same	NULL
efficiency	NULL
as	NULL
by	NULL
O54bp	NULL
(	NULL
Figure	NULL
5A	NULL
)	NULL
.	NULL

The	NULL
free	NULL
oligo	NULL
262	NULL
EBNA2Z	NULL
interaction	NULL
with	NULL
TP1	NULL
promoter	NULL
3	NULL
1	NULL
2	NULL
3	NULL
th	NULL
&	NULL
-	NULL
Va	NULL
a	NULL
-	NULL
IVb	NULL
-	NULL
Ill	NULL
free	NULL
oligo	NULL
-	NULL
209	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Competition	NULL
assays	NULL
demonstrate	NULL
the	NULL
specificity	NULL
of	NULL
complexes	NULL
I	NULL
,	NULL
III	NULL
and	NULL
IVA	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Autoradiogram	NULL
of	NULL
an	NULL
EMSA	NULL
.	NULL

Nuclear	NULL
extracts	NULL
of	NULL
Raji	NULL
cells	NULL
(	NULL
EBNA2ZA	NULL
positive	NULL
B-cell	NULL
line	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
labelled	NULL
oligonucleotide	NULL
O54bp	NULL
.	NULL

Unlabelled	NULL
oligonucleotides	NULL
054bp	NULL
,	NULL
O1	NULL
,	NULL
O2	NULL
and	NULL
11mut	NULL
were	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
mixture	NULL
in	NULL
10-	NULL
,	NULL
50-	NULL
and	NULL
100-fold	NULL
excesses	NULL
.	NULL

The	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Nuclear	NULL
extracts	NULL
of	NULL
HH514	NULL
,	NULL
Jijoye	NULL
and	NULL
M-ABA	NULL
cells	NULL
(	NULL
indicated	NULL
by	NULL
1	NULL
,	NULL
2	NULL
and	NULL
3	NULL
respectively	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
radioactively	NULL
labelled	NULL
O54bp	NULL
oligonucleotide	NULL
.	NULL

For	NULL
competition	NULL
unlabelled	NULL
oligonucleotide	NULL
O54bp	NULL
was	NULL
added	NULL
in	NULL
100-fold	NULL
excess	NULL
to	NULL
the	NULL
reaction	NULL
mixture	NULL
.	NULL

The	NULL
resulting	NULL
products	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
the	NULL
oligonucleotides	NULL
used	NULL
in	NULL
the	NULL
EMSA	NULL
.	NULL

The	NULL
indicated	NULL
positions	NULL
correspond	NULL
to	NULL
the	NULL
TP7	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

An	NULL
11	NULL
bp	NULL
motif	NULL
duplicated	NULL
in	NULL
O054bp	NULL
is	NULL
marked	NULL
by	NULL
dotted	NULL
boxes	NULL
,	NULL
the	NULL
10	NULL
bp	NULL
overlapping	NULL
region	NULL
of	NULL
O1	NULL
and	NULL
O2	NULL
by	NULL
hatched	NULL
boxes	NULL
.	NULL

two	NULL
oligonucleotides	NULL
share	NULL
a	NULL
10	NULL
bp	NULL
overlapping	NULL
region	NULL
and	NULL
a	NULL
common	NULL
motif	NULL
of	NULL
11	NULL
bp	NULL
(	NULL
Figure	NULL
5C	NULL
)	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
the	NULL
11	NULL
bp	NULL
motif	NULL
was	NULL
involved	NULL
in	NULL
the	NULL
protein-DNA	NULL
interaction	NULL
,	NULL
these	NULL
sequences	NULL
were	NULL
truncated	NULL
(	NULL
oligo	NULL
11mut	NULL
,	NULL
Figure	NULL
5C	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
5A	NULL
,	NULL
the	NULL
truncated	NULL
oligonucleotide	NULL
has	NULL
completely	NULL
lost	NULL
the	NULL
ability	NULL
to	NULL
prevent	NULL
formation	NULL
of	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
11	NULL
bp	NULL
motif	NULL
is	NULL
important	NULL
for	NULL
protein-DNA	NULL
interaction	NULL
within	NULL
the	NULL
EBNA2	NULL
responsive	NULL
region	NULL
.	NULL

EBNAZ	NULL
is	NULL
present	NULL
in	NULL
DNA-protein	NULL
complexes	NULL
formed	NULL
with	NULL
the	NULL
EBNAZ	NULL
responsive	NULL
region	NULL
Differences	NULL
between	NULL
EBNAZ	NULL
positive	NULL
and	NULL
negative	NULL
cell	NULL
lines	NULL
detected	NULL
in	NULL
the	NULL
EMSAs	NULL
described	NULL
above	NULL
were	NULL
low	NULL
mobility	NULL
complexes	NULL
IVA	NULL
and	NULL
IVB	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
EBNA2	NULL
was	NULL
present	NULL
in	NULL
any	NULL
of	NULL
the	NULL
complexes	NULL
described	NULL
above	NULL
,	NULL
DNA	NULL
binding	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
HH514	NULL
,	NULL
Jijoye	NULL
and	NULL
M-ABA	NULL
extracts	NULL
(	NULL
EBNAZ	NULL
negative	NULL
,	NULL
EBNA2B	NULL
positive	NULL
and	NULL
EBNAZA	NULL
positive	NULL
,	NULL
respectively	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
monoclonal	NULL
antibodies	NULL
raised	NULL
against	NULL
EBNAZA	NULL
.	NULL

The	NULL
monoclonal	NULL
antibody	NULL
EBNA2Z-R	NULL
1	NULL
is	NULL
able	NULL
to	NULL
detect	NULL
EBNA2ZA	NULL
as	NULL
well	NULL
as	NULL
EBNA2B	NULL
,	NULL
whereas	NULL
anti-EBNA2Z-R2	NULL
recognizes	NULL
EBNAZA	NULL
but	NULL
has	NULL
only	NULL
a	NULL
very	NULL
low	NULL
affinity	NULL
for	NULL
EBNA2B	NULL
in	NULL
immunoprecipitation	NULL
(	NULL
Kremmer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

Two	NULL
nonspecific	NULL
antibodies	NULL
,	NULL
raised	NULL
against	NULL
murine	NULL
CD45	NULL
,	NULL
of	NULL
the	NULL
same	NULL
isotype	NULL
as	NULL
the	NULL
anti-EBNA2Z-R1	NULL
and	NULL
anti-EBNA2-R2	NULL
antibodies	NULL
were	NULL
used	NULL
as	NULL
a	NULL
control	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
the	NULL
anti-EBNAZ-R1	NULL
antibody	NULL
resulted	NULL
in	NULL
a	NULL
supershift	NULL
of	NULL
complex	NULL
IVB	NULL
in	NULL
Jijoye	NULL
and	NULL
complex	NULL
IVA	NULL
in	NULL
M-ABA	NULL
extracts	NULL
(	NULL
Figure	NULL
6A	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
anti-EBNA2Z-R2	NULL
,	NULL
which	NULL
recognizes	NULL
EBNAZA	NULL
with	NULL
a	NULL
high	NULL
affinity	NULL
but	NULL
EBNA2B	NULL
with	NULL
a	NULL
very	NULL
low	NULL
affinity	NULL
,	NULL
led	NULL
to	NULL
a	NULL
supershift	NULL
of	NULL
complex	NULL
IVA	NULL
but	NULL
not	NULL
of	NULL
complex	NULL
IVB	NULL
.	NULL

Both	NULL
control	NULL
antibodies	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
mobility	NULL
of	NULL
complexes	NULL
IVA	NULL
and	NULL
IVB	NULL
.	NULL

We	NULL
have	NULL
repeated	NULL
the	NULL
experiments	NULL
with	NULL
two	NULL
further	NULL
EBNAZ2	NULL
monoclonals	NULL
,	NULL
anti-EBNA2Z-R3	NULL
and	NULL
anti-EBNA2-R11	NULL
.	NULL

Both	NULL
antibodies	NULL
recognized	NULL
EBNAZA	NULL
,	NULL
whereas	NULL
EBNA2ZB	NULL
was	NULL
recognized	NULL
only	NULL
by	NULL
EBNA2Z-R3	NULL
.	NULL

We	NULL
got	NULL
the	NULL
same	NULL
results	NULL
as	NULL
with	NULL
the	NULL
antibodies	NULL
described	NULL
above	NULL
.	NULL

Both	NULL
antibodies	NULL
caused	NULL
a	NULL
supershift	NULL
of	NULL
complex	NULL
IVa	NULL
,	NULL
but	NULL
only	NULL
anti-EBNA2-R3	NULL
was	NULL
able	NULL
to	NULL
supershift	NULL
complex	NULL
IVb	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
imply	NULL
that	NULL
complex	NULL
IVA	NULL
contains	NULL
EBNA2ZA	NULL
and	NULL
complex	NULL
IVB	NULL
EBNA2ZB	NULL
.	NULL

None	NULL
of	NULL
the	NULL
other	NULL
complexes	NULL
171	NULL
U.Zimber-Strobl	NULL
et	NULL
al	NULL
.	NULL

Ptifdiit	NULL
.	NULL

«	NULL
an	NULL
an	NULL
an	NULL
@	NULL
b	NULL
an	NULL
ab	NULL
om	NULL
&	NULL
”	NULL
ﬂ	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

EBNA2	NULL
is	NULL
a	NULL
component	NULL
of	NULL
complex	NULL
IV	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Effect	NULL
of	NULL
monoclonal	NULL
EBNAZ	NULL
antibodies	NULL
on	NULL
TP/	NULL
promoter	NULL
DNA-protein	NULL
complexes	NULL
.	NULL

Gel-shift	NULL
reactions	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
indicated	NULL
antibodies	NULL
.	NULL

Anti-EBNA2-R1	NULL
and	NULL
anti-EBNA2-R2	NULL
are	NULL
monoclonal	NULL
rat	NULL
antibodies	NULL
raised	NULL
against	NULL
EBNAZA	NULL
.	NULL

Anti-EBNAZ-R1	NULL
recognizes	NULL
EBNAZA	NULL
as	NULL
well	NULL
as	NULL
EBNA2B	NULL
;	NULL
anti-EBNA2-R2	NULL
recognizes	NULL
EBNA2A	NULL
with	NULL
the	NULL
same	NULL
affinity	NULL
as	NULL
anti-EBNA2Z-R1	NULL
,	NULL
but	NULL
only	NULL
recognizes	NULL
EBNA2B	NULL
with	NULL
a	NULL
very	NULL
low	NULL
affinity	NULL
.	NULL

Incubation	NULL
reactions	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Only	NULL
complexed	NULL
DNA	NULL
is	NULL
visible	NULL
on	NULL
the	NULL
autoradiogram	NULL
since	NULL
the	NULL
free	NULL
oligonucleotide	NULL
was	NULL
run	NULL
off	NULL
the	NULL
gel	NULL
.	NULL

1	NULL
,	NULL
2	NULL
and	NULL
3	NULL
indicate	NULL
gel-shift	NULL
reactions	NULL
with	NULL
extracts	NULL
of	NULL
cell	NULL
lines	NULL
HH514	NULL
(	NULL
EBNAZ	NULL
negative	NULL
)	NULL
,	NULL
Jijoye	NULL
(	NULL
EBNA2B	NULL
)	NULL
and	NULL
M-ABA	NULL
(	NULL
EBNAZA	NULL
)	NULL
respectively	NULL
.	NULL

Anti-mouse	NULL
CD45	NULL
IgG1	NULL
and	NULL
IgG2a	NULL
are	NULL
two	NULL
control	NULL
monoclonal	NULL
antibodies	NULL
of	NULL
the	NULL
same	NULL
Ig	NULL
subclasses	NULL
as	NULL
anti-EBNAZ-R1	NULL
and	NULL
anti-EBNAZ-R2	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
recognize	NULL
neither	NULL
EBNAZA	NULL
nor	NULL
EBNA2B	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Effect	NULL
of	NULL
in	NULL
vitro	NULL
translated	NULL
EBNAZA	NULL
on	NULL
the	NULL
reconstitution	NULL
of	NULL
complex	NULL
IV	NULL
.	NULL

Gel-shift	NULL
reactions	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
indicated	NULL
nuclear	NULL
extracts	NULL
(	NULL
NE	NULL
)	NULL
.	NULL

3	NULL
l	NULL
reticulocyte	NULL
lysate	NULL
(	NULL
IVT	NULL
)	NULL
programmed	NULL
with	NULL
EBNA2	NULL
RNA	NULL
or	NULL
BMV	NULL
RNA	NULL
and	NULL
1	NULL
4l	NULL
supernatant	NULL
of	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
anti-EBNA2-R3	NULL
or	NULL
anti-mouse	NULL
CD45	NULL
)	NULL
were	NULL
added	NULL
as	NULL
indicated	NULL
above	NULL
.	NULL

The	NULL
reactions	NULL
were	NULL
preincubated	NULL
for	NULL
5	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
before	NULL
adding	NULL
the	NULL
radioactively	NULL
labelled	NULL
oligonucleotide	NULL
O54bp	NULL
.	NULL

The	NULL
DNA	NULL
protein	NULL
complexes	NULL
were	NULL
analysed	NULL
on	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

The	NULL
free	NULL
oligonucleotide	NULL
was	NULL
run	NULL
off	NULL
the	NULL
gel	NULL
.	NULL

were	NULL
affected	NULL
by	NULL
the	NULL
monoclonal	NULL
EBNA2Z	NULL
antibodies	NULL
,	NULL
suggesting	NULL
that	NULL
they	NULL
do	NULL
not	NULL
contain	NULL
EBNA2	NULL
.	NULL

We	NULL
confirmed	NULL
that	NULL
EBNA2	NULL
is	NULL
really	NULL
a	NULL
component	NULL
of	NULL
the	NULL
protein-DNA	NULL
complex	NULL
IV	NULL
by	NULL
studying	NULL
the	NULL
ability	NULL
of	NULL
in	NULL
vitro	NULL
synthesized	NULL
EBNAZ	NULL
to	NULL
form	NULL
this	NULL
complex	NULL
.	NULL

The	NULL
EBNA2	NULL
ORF	NULL
was	NULL
translated	NULL
in	NULL
a	NULL
reticulocyte	NULL
lysate	NULL
.	NULL

The	NULL
in	NULL
vitro	NULL
synthesized	NULL
EBNA2	NULL
was	NULL
added	NULL
to	NULL
the	NULL
EBNA2Z	NULL
negative	NULL
BLA41-P3HR1	NULL
extracts	NULL
and	NULL
EMSAs	NULL
were	NULL
performed	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
6B	NULL
the	NULL
in	NULL
vitro	NULL
translated	NULL
EBNA2	NULL
formed	NULL
a	NULL
more	NULL
slowly	NULL
migrating	NULL
complex	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
addition	NULL
of	NULL
a	NULL
control	NULL
reticulocyte	NULL
lysate	NULL
containing	NULL
in	NULL
vitro	NULL
translated	NULL
brome	NULL
mosaic	NULL
virus	NULL
(	NULL
BMV	NULL
)	NULL
RNA	NULL
did	NULL
not	NULL
induce	NULL
this	NULL
complex	NULL
.	NULL

That	NULL
the	NULL
complex	NULL
induced	NULL
by	NULL
in	NULL
vitro	NULL
translated	NULL
EBNAZ	NULL
did	NULL
contain	NULL
the	NULL
added	NULL
EBNA2Z	NULL
was	NULL
confirmed	NULL
by	NULL
assaying	NULL
the	NULL
effect	NULL
of	NULL
monoclonal	NULL
antibodies	NULL
.	NULL

Anti-EBNAZ-R3	NULL
but	NULL
not	NULL
the	NULL
control	NULL
antibody	NULL
(	NULL
anti-CD45	NULL
)	NULL
induced	NULL
a	NULL
supershift	NULL
of	NULL
the	NULL
newly	NULL
formed	NULL
complex	NULL
.	NULL

An	NULL
additional	NULL
complex	NULL
(	NULL
*	NULL
)	NULL
appeared	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
nuclear	NULL
extracts	NULL
,	NULL
EBNA2	NULL
and	NULL
monoclonal	NULL
anti-EBNA2	NULL
antibodies	NULL
in	NULL
this	NULL
experiment	NULL
.	NULL

This	NULL
complex	NULL
was	NULL
not	NULL
always	NULL
reproducible	NULL
and	NULL
is	NULL
therefore	NULL
not	NULL
further	NULL
considered	NULL
.	NULL

Besides	NULL
the	NULL
in	NULL
vitro	NULL
translated	NULL
EBNA2	NULL
diminished	NULL
formation	NULL
of	NULL
complexes	NULL
I	NULL
and	NULL
III	NULL
.	NULL

Whether	NULL
this	NULL
effect	NULL
is	NULL
specific	NULL
or	NULL
not	NULL
is	NULL
still	NULL
unclear	NULL
.	NULL

The	NULL
in	NULL
vitro	NULL
translated	NULL
EBNA2	NULL
was	NULL
not	NULL
able	NULL
to	NULL
bind	NULL
DNA	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
nuclear	NULL
extracts	NULL
,	NULL
suggesting	NULL
that	NULL
EBNAZ	NULL
interacts	NULL
with	NULL
DNA	NULL
not	NULL
directly	NULL
but	NULL
indirectly	NULL
.	NULL

172	NULL
Discussion	NULL
It	NULL
is	NULL
assumed	NULL
that	NULL
the	NULL
contribution	NULL
of	NULL
EBNA2Z	NULL
to	NULL
B-cell	NULL
immortalization	NULL
is	NULL
conferred	NULL
by	NULL
its	NULL
ability	NULL
to	NULL
transactivate	NULL
viral	NULL
and	NULL
cellular	NULL
genes	NULL
.	NULL

In	NULL
order	NULL
to	NULL
understand	NULL
the	NULL
process	NULL
of	NULL
immortalization	NULL
at	NULL
a	NULL
molecular	NULL
level	NULL
,	NULL
it	NULL
is	NULL
essential	NULL
to	NULL
elucidate	NULL
the	NULL
mechanism	NULL
of	NULL
EBNA2	NULL
mediated	NULL
transactivation	NULL
.	NULL

We	NULL
chose	NULL
the	NULL
TPZ	NULL
promoter	NULL
as	NULL
a	NULL
model	NULL
system	NULL
for	NULL
studying	NULL
EBNA2	NULL
dependent	NULL
transcription	NULL
.	NULL

As	NULL
shown	NULL
previously	NULL
,	NULL
7P7	NULL
transcription	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
EBNAZ	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cells	NULL
(	NULL
Zimber-Strobl	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Our	NULL
first	NULL
aim	NULL
was	NULL
to	NULL
identify	NULL
a	NULL
cis-acting	NULL
element	NULL
mediating	NULL
EBNA2	NULL
responsiveness	NULL
.	NULL

Therefore	NULL
we	NULL
transfected	NULL
different	NULL
TPZ	NULL
promoter-reporter	NULL
gene	NULL
constructs	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
EBNAZ	NULL
.	NULL

By	NULL
this	NULL
approach	NULL
we	NULL
were	NULL
able	NULL
to	NULL
identify	NULL
an	NULL
81	NULL
bp	NULL
element	NULL
between	NULL
positions	NULL
-177	NULL
and	NULL
-258	NULL
which	NULL
is	NULL
sufficient	NULL
to	NULL
confer	NULL
EBNA2	NULL
responsiveness	NULL
.	NULL

The	NULL
EBNAZ	NULL
responsive	NULL
element	NULL
(	NULL
EBNA2ZRE	NULL
)	NULL
works	NULL
in	NULL
either	NULL
orientation	NULL
and	NULL
is	NULL
able	NULL
to	NULL
regulate	NULL
a	NULL
heterologous	NULL
promoter	NULL
.	NULL

These	NULL
results	NULL
imply	NULL
that	NULL
EBNA2	NULL
responsiveness	NULL
is	NULL
conferred	NULL
by	NULL
an	NULL
enhancer-like	NULL
cis-element	NULL
.	NULL

This	NULL
observation	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
reports	NULL
.	NULL

EBNA2	NULL
responsive	NULL
elements	NULL
were	NULL
also	NULL
identified	NULL
within	NULL
the	NULL
LMP	NULL
,	NULL
BamHI-C	NULL
and	NULL
CD23	NULL
promoters	NULL
and	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
they	NULL
work	NULL
in	NULL
an	NULL
orientation	NULL
independent	NULL
fashion	NULL
and	NULL
regulate	NULL
a	NULL
heterologous	NULL
promoter	NULL
(	NULL
Sung	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Tsang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Wang	NULL
ert	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Woisetschlaeger	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

We	NULL
performed	NULL
EMSAs	NULL
to	NULL
identify	NULL
specific	NULL
protein-DNA	NULL
interactions	NULL
within	NULL
the	NULL
7P/	NULL
promoter	NULL
.	NULL

One	NULL
prominent	NULL
DNA-protein	NULL
complex	NULL
(	NULL
I	NULL
)	NULL
and	NULL
two	NULL
weaker	NULL
complexes	NULL
(	NULL
II	NULL
and	NULL
III	NULL
)	NULL
were	NULL
detected	NULL
with	NULL
a	NULL
radioactively	NULL
labelled	NULL
fragment	NULL
spanning	NULL
the	NULL
7P/	NULL
promoter	NULL
from	NULL
position	NULL
-12	NULL
to	NULL
-258	NULL
(	NULL
5'-end	NULL
of	NULL
the	NULL
EBNAZRE	NULL
)	NULL
.	NULL

It	NULL
was	NULL
possible	NULL
to	NULL
compete	NULL
specifically	NULL
complexes	NULL
I	NULL
and	NULL
III	NULL
with	NULL
two	NULL
oligonucleotides	NULL
spanning	NULL
the	NULL
region	NULL
-262	NULL
to	NULL
-230	NULL
and	NULL
-239	NULL
to	NULL
-209	NULL
.	NULL

When	NULL
extracts	NULL
were	NULL
mixed	NULL
with	NULL
a	NULL
radioactive	NULL
oligonucleotide	NULL
from	NULL
position	NULL
-262	NULL
to	NULL
-209	NULL
and	NULL
EMSAs	NULL
were	NULL
performed	NULL
,	NULL
the	NULL
same	NULL
pattern	NULL
of	NULL
complex	NULL
formation	NULL
occurred	NULL
.	NULL

These	NULL
experiments	NULL
indicate	NULL
that	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
interact	NULL
with	NULL
sequences	NULL
located	NULL
in	NULL
the	NULL
EBNA2ZRE	NULL
.	NULL

Formation	NULL
of	NULL
complexes	NULL
I	NULL
,	NULL
II	NULL
and	NULL
III	NULL
appeared	NULL
to	NULL
be	NULL
independent	NULL
of	NULL
EBNAZ	NULL
and	NULL
even	NULL
independent	NULL
of	NULL
the	NULL
cellular	NULL
background	NULL
of	NULL
B-cells	NULL
,	NULL
since	NULL
they	NULL
were	NULL
detected	NULL
in	NULL
all	NULL
cell	NULL
lines	NULL
studied	NULL
.	NULL

This	NULL
implies	NULL
binding	NULL
of	NULL
a	NULL
universal	NULL
transcription	NULL
factor	NULL
.	NULL

We	NULL
were	NULL
not	NULL
able	NULL
to	NULL
identify	NULL
this	NULL
factor	NULL
by	NULL
comparing	NULL
the	NULL
sequence	NULL
with	NULL
known	NULL
consensus	NULL
sequences	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
Ghosh	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

The	NULL
only	NULL
obvious	NULL
cognate	NULL
nuclear	NULL
factor	NULL
binding	NULL
sequence	NULL
in	NULL
the	NULL
54	NULL
bp	NULL
fragment	NULL
is	NULL
one	NULL
SP1	NULL
consensus	NULL
sequence	NULL
at	NULL
position	NULL
-240	NULL
.	NULL

Addition	NULL
of	NULL
a	NULL
500-fold	NULL
excess	NULL
of	NULL
an	NULL
unlabelled	NULL
oligonucleotide	NULL
representing	NULL
the	NULL
SP1	NULL
binding	NULL
site	NULL
failed	NULL
to	NULL
compete	NULL
the	NULL
shift	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

It	NULL
is	NULL
therefore	NULL
unlikely	NULL
that	NULL
this	NULL
SP1	NULL
site	NULL
plays	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
the	NULL
observed	NULL
DNA-protein	NULL
interaction	NULL
.	NULL

Formation	NULL
of	NULL
all	NULL
complexes	NULL
except	NULL
complex	NULL
II	NULL
was	NULL
competed	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
unlabelled	NULL
O1	NULL
as	NULL
well	NULL
as	NULL
O2	NULL
.	NULL

These	NULL
two	NULL
oligonucleotides	NULL
share	NULL
a	NULL
10	NULL
bp	NULL
overlapping	NULL
region	NULL
and	NULL
a	NULL
common	NULL
motif	NULL
of	NULL
11	NULL
bp	NULL
.	NULL

The	NULL
11	NULL
bp	NULL
motif	NULL
seems	NULL
to	NULL
play	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
DNA-protein	NULL
interactions	NULL
,	NULL
since	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
complete	NULL
10	NULL
bp	NULL
overlap	NULL
,	NULL
but	NULL
two	NULL
truncated	NULL
11	NULL
bp	NULL
motifs	NULL
,	NULL
has	NULL
lost	NULL
the	NULL
ability	NULL
to	NULL
inhibit	NULL
the	NULL
protein	NULL
binding	NULL
of	NULL
the	NULL
54	NULL
bp	NULL
oligonucleotide	NULL
.	NULL

Realizing	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
11	NULL
bp	NULL
motif	NULL
we	NULL
searched	NULL
for	NULL
this	NULL
sequence	NULL
in	NULL
the	NULL
EBNA2	NULL
responsive	NULL
regions	NULL
of	NULL
the	NULL
BamHI-C	NULL
and	NULL
LMP	NULL
promoters	NULL
which	NULL
were	NULL
shown	NULL
to	NULL
be	NULL
activated	NULL
by	NULL
EBNAZ	NULL
.	NULL

Sung	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
reported	NULL
an	NULL
EBNA2	NULL
responsive	NULL
region	NULL
of	NULL
98	NULL
bp	NULL
within	NULL
the	NULL
BamHI-C	NULL
promoter	NULL
between	NULL
positions	NULL
-367	NULL
and	NULL
-465	NULL
.	NULL

In	NULL
the	NULL
LMP	NULL
promoter	NULL
,	NULL
Tsang	NULL
ert	NULL
al	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
described	NULL
an	NULL
element	NULL
of	NULL
30	NULL
bp	NULL
between	NULL
positions	NULL
-234	NULL
and	NULL
-205	NULL
which	NULL
is	NULL
essential	NULL
although	NULL
not	NULL
sufficient	NULL
for	NULL
EBNA2	NULL
responsiveness	NULL
.	NULL

Remarkably	NULL
,	NULL
the	NULL
BamHI-C	NULL
promoter	NULL
contains	NULL
,	NULL
at	NULL
position	NULL
-371	NULL
,	NULL
a	NULL
10	NULL
bp	NULL
sequence	NULL
that	NULL
is	NULL
identical	NULL
to	NULL
the	NULL
11	NULL
bp	NULL
motif	NULL
,	NULL
and	NULL
the	NULL
LMP	NULL
promoter	NULL
contains	NULL
,	NULL
at	NULL
position	NULL
-218	NULL
,	NULL
a	NULL
sequence	NULL
that	NULL
shares	NULL
7	NULL
bp	NULL
(	NULL
GTGGGAA	NULL
)	NULL
of	NULL
the	NULL
11	NULL
bp	NULL
motif	NULL
.	NULL

Recently	NULL
it	NULL
was	NULL
shown	NULL
by	NULL
footprint	NULL
analyses	NULL
that	NULL
parts	NULL
of	NULL
the	NULL
10	NULL
bp	NULL
motif	NULL
of	NULL
the	NULL
BamHI-C	NULL
promoter	NULL
interact	NULL
with	NULL
a	NULL
DNA	NULL
binding	NULL
protein	NULL
(	NULL
Jin	NULL
and	NULL
Speck	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

Taking	NULL
this	NULL
into	NULL
account	NULL
,	NULL
it	NULL
seems	NULL
likely	NULL
that	NULL
the	NULL
11	NULL
bp	NULL
motif	NULL
plays	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
EBNA2	NULL
mediated	NULL
transactivation	NULL
.	NULL

Is	NULL
EBNA2	NULL
a	NULL
component	NULL
of	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
?	NULL

As	NULL
mentioned	NULL
above	NULL
,	NULL
EBNA2	NULL
positive	NULL
and	NULL
negative	NULL
cell	NULL
extracts	NULL
showed	NULL
almost	NULL
identical	NULL
binding	NULL
patterns	NULL
in	NULL
EMSA	NULL
.	NULL

Only	NULL
a	NULL
very	NULL
slowly	NULL
migrating	NULL
band	NULL
(	NULL
IVA	NULL
or	NULL
IVB	NULL
)	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
Raji	NULL
,	NULL
M-ABA	NULL
and	NULL
Jijoye	NULL
extracts	NULL
,	NULL
which	NULL
was	NULL
missing	NULL
in	NULL
all	NULL
EBNAZ	NULL
negative	NULL
cell	NULL
extracts	NULL
.	NULL

We	NULL
mixed	NULL
EBNAZ	NULL
specific	NULL
monoclonal	NULL
antibodies	NULL
in	NULL
the	NULL
EMSA	NULL
to	NULL
EBNA2	NULL
interaction	NULL
with	NULL
TP1	NULL
promoter	NULL
study	NULL
whether	NULL
one	NULL
of	NULL
the	NULL
retarded	NULL
bands	NULL
contained	NULL
EBNA2	NULL
.	NULL

Addition	NULL
of	NULL
EBNA2Z	NULL
antibodies	NULL
resulted	NULL
in	NULL
a	NULL
supershift	NULL
of	NULL
complexes	NULL
IVA	NULL
and	NULL
IVB	NULL
.	NULL

An	NULL
antibody	NULL
recognizing	NULL
only	NULL
EBNAZA	NULL
induced	NULL
a	NULL
supershift	NULL
of	NULL
complex	NULL
IVA	NULL
only	NULL
,	NULL
whereas	NULL
an	NULL
antibody	NULL
specific	NULL
for	NULL
EBNA2ZA	NULL
and	NULL
EBNA2B	NULL
retarded	NULL
migration	NULL
of	NULL
both	NULL
complexes	NULL
IVA	NULL
and	NULL
IVB	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
EBNA2B	NULL
is	NULL
a	NULL
component	NULL
of	NULL
complex	NULL
IVB	NULL
and	NULL
EBNAZA	NULL
a	NULL
component	NULL
of	NULL
complex	NULL
IVA	NULL
.	NULL

To	NULL
prove	NULL
that	NULL
EBNA2	NULL
is	NULL
indeed	NULL
a	NULL
component	NULL
of	NULL
complex	NULL
IV	NULL
,	NULL
we	NULL
added	NULL
in	NULL
vitro	NULL
translated	NULL
EBNAZ	NULL
to	NULL
EBNA2	NULL
negative	NULL
BL41-P3HR	NULL
1	NULL
extracts	NULL
and	NULL
performed	NULL
EMSAs	NULL
.	NULL

The	NULL
in	NULL
vitro	NULL
translated	NULL
EBNA2	NULL
induced	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
more	NULL
slowly	NULL
migrating	NULL
complex	NULL
.	NULL

By	NULL
adding	NULL
monoclonal	NULL
antibodies	NULL
we	NULL
showed	NULL
that	NULL
the	NULL
EBNA2-induced	NULL
complex	NULL
contained	NULL
the	NULL
added	NULL
EBNA2	NULL
.	NULL

The	NULL
complex	NULL
containing	NULL
the	NULL
in	NULL
vitro	NULL
translated	NULL
EBNA2	NULL
migrated	NULL
slightly	NULL
faster	NULL
than	NULL
complex	NULL
IVa	NULL
visible	NULL
in	NULL
M-ABA	NULL
extracts	NULL
.	NULL

This	NULL
phenomenon	NULL
could	NULL
be	NULL
caused	NULL
by	NULL
different	NULL
modifications	NULL
of	NULL
the	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
synthesized	NULL
EBNA2	NULL
.	NULL

Although	NULL
the	NULL
54	NULL
bp	NULL
fragment	NULL
is	NULL
sufficient	NULL
to	NULL
bind	NULL
EBNA2	NULL
,	NULL
it	NULL
is	NULL
not	NULL
able	NULL
to	NULL
mediate	NULL
EBNA2Z	NULL
responsiveness	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
sequences	NULL
between	NULL
-209	NULL
and	NULL
-177	NULL
are	NULL
necessary	NULL
for	NULL
EBNA2	NULL
dependent	NULL
transactivation	NULL
.	NULL

It	NULL
is	NULL
conceivable	NULL
that	NULL
an	NULL
additional	NULL
protein	NULL
binds	NULL
to	NULL
these	NULL
sequences	NULL
and	NULL
contributes	NULL
to	NULL
EBNA2	NULL
responsiveness	NULL
.	NULL

Here	NULL
we	NULL
have	NULL
shown	NULL
for	NULL
the	NULL
first	NULL
time	NULL
that	NULL
EBNA2Z	NULL
is	NULL
present	NULL
in	NULL
complexes	NULL
of	NULL
specific	NULL
DNA	NULL
sequences	NULL
and	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
.	NULL

Our	NULL
experiments	NULL
suggest	NULL
that	NULL
EBNAZ	NULL
interacts	NULL
with	NULL
DNA	NULL
indirectly	NULL
via	NULL
protein-protein	NULL
interactions	NULL
.	NULL

Such	NULL
interactions	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
transactivation	NULL
by	NULL
E1A	NULL
and	NULL
VP16	NULL
(	NULL
Lillie	NULL
and	NULL
Green	NULL
,	NULL
1989	NULL
;	NULL
Stern	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Liu	NULL
and	NULL
Green	NULL
,	NULL
1990	NULL
)	NULL
transactivators	NULL
of	NULL
adenovirus	NULL
and	NULL
herpes	NULL
simplex	NULL
virus	NULL
,	NULL
respectively	NULL
.	NULL

VP16	NULL
binds	NULL
to	NULL
the	NULL
universal	NULL
transcription	NULL
factor	NULL
Oct1	NULL
,	NULL
juxtaposing	NULL
the	NULL
transactivation	NULL
domain	NULL
of	NULL
VP16	NULL
to	NULL
the	NULL
promoter	NULL
.	NULL

It	NULL
seems	NULL
likely	NULL
that	NULL
EBNAZ	NULL
also	NULL
interacts	NULL
with	NULL
a	NULL
transcription	NULL
factor	NULL
,	NULL
perhaps	NULL
contained	NULL
in	NULL
complexI	NULL
and/or	NULL
III	NULL
.	NULL

We	NULL
are	NULL
in	NULL
the	NULL
process	NULL
of	NULL
identifying	NULL
the	NULL
factors	NULL
interacting	NULL
with	NULL
the	NULL
EBNAZRE	NULL
of	NULL
the	NULL
TPZ	NULL
promoter	NULL
,	NULL
which	NULL
should	NULL
further	NULL
elucidate	NULL
EBNA2	NULL
mediated	NULL
transactivation	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Cell	NULL
lines	NULL
and	NULL
culture	NULL
conditions	NULL
Cell	NULL
lines	NULL
M-ABA	NULL
,	NULL
Raji	NULL
and	NULL
BL41	NULL
have	NULL
been	NULL
described	NULL
elsewhere	NULL
(	NULL
Crawford	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1979	NULL
;	NULL
Pulvertaft	NULL
,	NULL
1965	NULL
;	NULL
Lenoir	NULL
er	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
)	NULL
.	NULL

HH514	NULL
is	NULL
a	NULL
single	NULL
cell	NULL
clone	NULL
of	NULL
Jijoye	NULL
,	NULL
carrying	NULL
a	NULL
deletion	NULL
in	NULL
the	NULL
EBNA2	NULL
gene	NULL
(	NULL
Hinuma	NULL
er	NULL
al	NULL
.	NULL

,	NULL
1967	NULL
;	NULL
Miller	NULL
er	NULL
al	NULL
.	NULL

,	NULL
1974	NULL
)	NULL
.	NULL

BL41-P3HR1	NULL
and	NULL
BL41-B95-8	NULL
were	NULL
obtained	NULL
after	NULL
infection	NULL
of	NULL
the	NULL
EBV	NULL
negative	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
line	NULL
BL41	NULL
with	NULL
virus	NULL
strains	NULL
P3HR1	NULL
and	NULL
B95-8	NULL
,	NULL
respectively	NULL
(	NULL
Calender	NULL
er	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
.	NULL

HL60	NULL
is	NULL
a	NULL
promyelocyte	NULL
cell	NULL
line	NULL
described	NULL
by	NULL
Collins	NULL
er	NULL
al	NULL
.	NULL

(	NULL
1978	NULL
)	NULL
.	NULL

All	NULL
cell	NULL
lines	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
100	NULL
U/ml	NULL
!	NULL

penicillin	NULL
and	NULL
100	NULL
ug/ml	NULL
streptomycin	NULL
.	NULL

Cultures	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
in	NULL
an	NULL
atmosphere	NULL
of	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
.	NULL

Cells	NULL
were	NULL
diluted	NULL
1:3	NULL
with	NULL
fresh	NULL
medium	NULL
twice	NULL
a	NULL
week	NULL
.	NULL

Plasmids	NULL
The	NULL
TP	NULL
]	NULL
promoter-CAT	NULL
construct	NULL
described	NULL
previously	NULL
(	NULL
Zimber-Strobl	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
was	NULL
cut	NULL
with	NULL
either	NULL
Sacll	NULL
(	NULL
-45	NULL
)	NULL
,	NULL
Smal	NULL
(	NULL
-	NULL
124	NULL
)	NULL
,	NULL
Pvull	NULL
(	NULL
-	NULL
177	NULL
)	NULL
,	NULL
Nrul	NULL
(	NULL
-258	NULL
)	NULL
,	NULL
HindII	NULL
(	NULL
-432	NULL
)	NULL
or	NULL
Nsit	NULL
(	NULL
-543	NULL
)	NULL
and	NULL
protruding	NULL
ends	NULL
were	NULL
filled	NULL
in	NULL
with	NULL
T4	NULL
polymerase	NULL
.	NULL

After	NULL
digestion	NULL
with	NULL
PsfI	NULL
the	NULL
fragments	NULL
containing	NULL
the	NULL
TP	NULL
]	NULL
promoter	NULL
region	NULL
were	NULL
isolated	NULL
and	NULL
inserted	NULL
into	NULL
the	NULL
filled	NULL
in	NULL
HindIII	NULL
and	NULL
Pst	NULL
]	NULL
sites	NULL
of	NULL
the	NULL
vector	NULL
pBLCATS	NULL
(	NULL
P.Herrlich	NULL
,	NULL
personal	NULL
communica-tion	NULL
)	NULL
.	NULL

pTPI-CAT/A-147/-258	NULL
was	NULL
constructed	NULL
by	NULL
Be/l	NULL
and	NULL
Nrul	NULL
digestion	NULL
of	NULL
pTPI-CAT/-543	NULL
.	NULL

pTPI-CAT/135bp	NULL
and	NULL
pTPIl-CAT/8lbp	NULL
were	NULL
generated	NULL
by	NULL
Smal	NULL
+Nrul	NULL
and	NULL
Pvull	NULL
+	NULL
Nrul	NULL
digestion	NULL
of	NULL
pTPI-CAT/-543	NULL
.	NULL

The	NULL
135	NULL
bp	NULL
and	NULL
81	NULL
bp	NULL
fragments	NULL
were	NULL
isolated	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
Stul	NULL
173	NULL
U.Zimber-Strobl	NULL
et	NULL
al	NULL
.	NULL

site	NULL
of	NULL
pTP1-CAT/-45	NULL
.	NULL

The	NULL
135	NULL
bp	NULL
fragment	NULL
was	NULL
also	NULL
cloned	NULL
into	NULL
the	NULL
filled	NULL
in	NULL
Sall	NULL
site	NULL
of	NULL
B-glob	NULL
-CAT	NULL
containing	NULL
the	NULL
-globin	NULL
minimal	NULL
promoter	NULL
in	NULL
front	NULL
of	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
(	NULL
Laux	NULL
et	NULL
al	NULL
.	NULL

,	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

All	NULL
LUC	NULL
constructs	NULL
were	NULL
obtained	NULL
by	NULL
digesting	NULL
pBLLUCS	NULL
(	NULL
Laux	NULL
er	NULL
a/	NULL
.	NULL

,	NULL
in	NULL
preparation	NULL
)	NULL
with	NULL
BamHI	NULL
and	NULL
Kpnl	NULL
.	NULL

The	NULL
fragment	NULL
containing	NULL
the	NULL
uc	NULL
gene	NULL
was	NULL
isolated	NULL
and	NULL
ligated	NULL
to	NULL
the	NULL
corresponding	NULL
pTP1-CAT	NULL
construct	NULL
also	NULL
digested	NULL
with	NULL
BamHI	NULL
and	NULL
KpnL	NULL
.	NULL

The	NULL
EBNA2	NULL
expression	NULL
vector	NULL
pU294-6	NULL
contains	NULL
an	NULL
EBV	NULL
fragment	NULL
from	NULL
position	NULL
35	NULL
448	NULL
to	NULL
54	NULL
360	NULL
according	NULL
to	NULL
the	NULL
B95-8	NULL
EBV	NULL
sequence	NULL
(	NULL
Baer	NULL
et	NULL
af	NULL
.	NULL

,	NULL
1984	NULL
)	NULL
.	NULL

The	NULL
clone	NULL
was	NULL
generated	NULL
by	NULL
deleting	NULL
the	NULL
NotI	NULL
repeats	NULL
of	NULL
pM780-28	NULL
described	NULL
by	NULL
Polack	NULL
er	NULL
al	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
.	NULL

pU812/9	NULL
was	NULL
generated	NULL
by	NULL
digesting	NULL
pU294-6	NULL
with	NULL
SphlL	NULL
and	NULL
religation	NULL
.	NULL

p6O4	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
W.Hammerschmidt	NULL
.	NULL

It	NULL
was	NULL
constructed	NULL
by	NULL
inserting	NULL
an	NULL
Xbal	NULL
linker	NULL
in	NULL
p135.15	NULL
(	NULL
Hammerschmidt	NULL
and	NULL
Sudgen	NULL
,	NULL
1989	NULL
)	NULL
at	NULL
position	NULL
48	NULL
950	NULL
according	NULL
to	NULL
the	NULL
B95-8	NULL
EBV	NULL
sequence	NULL
published	NULL
by	NULL
Baer	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
.	NULL

The	NULL
CMV-LTR-CAT	NULL
construct	NULL
was	NULL
obtained	NULL
from	NULL
L.S.Y.Chen	NULL
(	NULL
Cann	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

The	NULL
plasmid	NULL
used	NULL
in	NULL
the	NULL
in	NULL
vitro	NULL
translation	NULL
of	NULL
EBNA2	NULL
was	NULL
constructed	NULL
by	NULL
inserting	NULL
the	NULL
genomic	NULL
B95-8	NULL
EBV	NULL
sequence	NULL
from	NULL
position	NULL
48	NULL
039	NULL
to	NULL
54	NULL
360	NULL
in	NULL
a	NULL
Bluescript	NULL
vector	NULL
digested	NULL
with	NULL
HindIII	NULL
and	NULL
BamHI	NULL
.	NULL

Just	NULL
in	NULL
front	NULL
of	NULL
the	NULL
translation	NULL
start	NULL
of	NULL
EBNA2	NULL
,	NULL
an	NULL
EcoRI	NULL
site	NULL
was	NULL
inserted	NULL
by	NULL
site	NULL
directed	NULL
mutagenesis	NULL
(	NULL
pBSmutC	NULL
)	NULL
.	NULL

pBSmutC	NULL
was	NULL
cut	NULL
with	NULL
HindIII	NULL
and	NULL
EcoRI	NULL
and	NULL
an	NULL
oligonucleotide	NULL
representing	NULL
a	NULL
ribosome	NULL
binding	NULL
site	NULL
was	NULL
inserted	NULL
(	NULL
pGa206/6	NULL
)	NULL
.	NULL

Oligonucleotides	NULL
The	NULL
positions	NULL
of	NULL
oligonucleotides	NULL
used	NULL
in	NULL
relation	NULL
to	NULL
the	NULL
EBV	NULL
genomic	NULL
sequence	NULL
according	NULL
to	NULL
Baer	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
are	NULL
as	NULL
follows	NULL
:	NULL
O1	NULL
,	NULL
166	NULL
236-166	NULL
268	NULL
;	NULL
02	NULL
,	NULL
166	NULL
259-166	NULL
289	NULL
;	NULL
03	NULL
,	NULL
166	NULL
279-166	NULL
317	NULL
;	NULL
O04	NULL
,	NULL
166	NULL
302-166	NULL
340	NULL
;	NULL
O54bp	NULL
,	NULL
166	NULL
236-166	NULL
289	NULL
;	NULL
and	NULL
11mut	NULL
,	NULL
166	NULL
252-166	NULL
272	NULL
.	NULL

Transfection	NULL
of	NULL
the	NULL
cells	NULL
Electroporation	NULL
of	NULL
cells	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Cann	NULL
et	NULL
a/	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
washed	NULL
once	NULL
and	NULL
resuspended	NULL
in	NULL
0.25	NULL
ml	NULL
fresh	NULL
ice-cold	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
placed	NULL
on	NULL
ice	NULL
in	NULL
a	NULL
Gene	NULL
Pulser	NULL
cuvette	NULL
,	NULL
and	NULL
20	NULL
ug	NULL
of	NULL
the	NULL
corresponding	NULL
DNA	NULL
was	NULL
added	NULL
.	NULL

Cells	NULL
were	NULL
electroporated	NULL
with	NULL
a	NULL
Bio-Rad	NULL
Gene	NULL
Pulser	NULL
at	NULL
250	NULL
V	NULL
and	NULL
960	NULL
uF	NULL
.	NULL

At	NULL
10	NULL
min	NULL
after	NULL
electroporation	NULL
,	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
10	NULL
ml	NULL
of	NULL
prewarmed	NULL
RPMI	NULL
with	NULL
20	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

CAT	NULL
assay	NULL
CAT	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Zimber-Strobl	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

CAT	NULL
activities	NULL
were	NULL
quantified	NULL
by	NULL
densitometrically	NULL
scanning	NULL
the	NULL
signals	NULL
of	NULL
an	NULL
autoradiogram	NULL
with	NULL
the	NULL
Cybertech	NULL
system	NULL
(	NULL
Appligene	NULL
)	NULL
.	NULL

LUC	NULL
assays	NULL
Cells	NULL
were	NULL
harvested	NULL
40	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
washed	NULL
once	NULL
in	NULL
ice-cold	NULL
PBS	NULL
and	NULL
resuspended	NULL
in	NULL
100	NULL
41	NULL
91	NULL
mM	NULL
K	NULL
;	NULL
HPO	NULL
,	NULL
,	NULL
9	NULL
mM	NULL
KH	NULL
;	NULL
PO	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
pH	NULL
7.8	NULL
.	NULL

Debris	NULL
was	NULL
removed	NULL
by	NULL
centrifugation	NULL
at	NULL
14	NULL
000	NULL
g	NULL
for	NULL
10	NULL
min	NULL
.	NULL

10	NULL
pl	NULL
of	NULL
the	NULL
supernatant	NULL
was	NULL
mixed	NULL
with	NULL
350	NULL
gl	NULL
25	NULL
mM	NULL
glycyl-glycine	NULL
,	NULL
pH	NULL
7.8	NULL
;	NULL
5	NULL
mM	NULL
ATP	NULL
;	NULL
15	NULL
mM	NULL
MgSO	NULL
,	NULL
and	NULL
100	NULL
al	NULL
1ImM	NULL
luciferin	NULL
;	NULL
0.5	NULL
M	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.8	NULL
.	NULL

The	NULL
bioluminescence	NULL
(	NULL
in	NULL
RLU	NULL
)	NULL
was	NULL
measured	NULL
with	NULL
a	NULL
Lumat	NULL
LB9501	NULL
(	NULL
Berthold	NULL
,	NULL
Wildbach	NULL
)	NULL
.	NULL

Nuclear	NULL
extract	NULL
preparation	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
a	NULL
modification	NULL
of	NULL
the	NULL
method	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
.	NULL

The	NULL
pellet	NULL
(	NULL
3-5	NULL
x	NULL
107	NULL
cells	NULL
)	NULL
was	NULL
washed	NULL
once	NULL
in	NULL
ice-cold	NULL
PBS	NULL
,	NULL
resuspended	NULL
with	NULL
3-4	NULL
vol	NULL
10	NULL
mM	NULL
HEPES	NULL
pH	NULL
7.9	NULL
;	NULL
10	NULL
mM	NULL
KCI	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
;	NULL
5	NULL
mM	NULL
DTT	NULL
;	NULL
0.5	NULL
mM	NULL
PMSF	NULL
(	NULL
buffer	NULL
A	NULL
)	NULL
and	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
1	NULL
h.	NULL
Lysis	NULL
of	NULL
cells	NULL
was	NULL
achieved	NULL
by	NULL
10-20	NULL
strokes	NULL
with	NULL
a	NULL
Dounce	NULL
homogenizer	NULL
,	NULL
microscopically	NULL
controlled	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
trypan	NULL
blue	NULL
.	NULL

Nuclei	NULL
were	NULL
pelleted	NULL
for	NULL
10	NULL
s	NULL
at	NULL
maximal	NULL
speed	NULL
in	NULL
an	NULL
Eppendorf	NULL
minifuge	NULL
,	NULL
washed	NULL
once	NULL
in	NULL
buffer	NULL
A	NULL
,	NULL
resuspended	NULL
in	NULL
3	NULL
vol	NULL
of	NULL
buffer	NULL
B	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
pH	NULL
7.9	NULL
;	NULL
20	NULL
%	NULL
glycerine	NULL
;	NULL
420	NULL
mM	NULL
NaCl	NULL
;	NULL
1.5	NULL
mM	NULL
MgCl	NULL
;	NULL
;	NULL
0.2	NULL
mM	NULL
EDTA	NULL
;	NULL
5	NULL
mM	NULL
DTT	NULL
;	NULL
0.5	NULL
mM	NULL
PMSF	NULL
)	NULL
and	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Nuclei	NULL
were	NULL
removed	NULL
by	NULL
centrifugation	NULL
at	NULL
14	NULL
000	NULL
g	NULL
for	NULL
20	NULL
min	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
stored	NULL
in	NULL
liquid	NULL
nitrogen	NULL
.	NULL

Gel-shift	NULL
analysis	NULL
Binding	NULL
reactions	NULL
were	NULL
performed	NULL
in	NULL
a	NULL
volume	NULL
of	NULL
20	NULL
pl	NULL
,	NULL
containing	NULL
5	NULL
Ll	NULL
binding	NULL
buffer	NULL
(	NULL
41	NULL
mM	NULL
HEPES	NULL
pH	NULL
7.9	NULL
;	NULL
200	NULL
mM	NULL
KCI	NULL
;	NULL
4	NULL
mM	NULL
EDTA	NULL
;	NULL
1.6	NULL
%	NULL
Ficoll	NULL
;	NULL
4	NULL
mM	NULL
DTT	NULL
;	NULL
0.5	NULL
mM	NULL
PMSF	NULL
)	NULL
,	NULL
2	NULL
gl	NULL
poly	NULL
(	NULL
dIdC	NULL
)	NULL
(	NULL
2	NULL
mg/m	NULL
!	NULL
)	NULL

,	NULL
2	NULL
ul	NULL
BSA	NULL
(	NULL
20	NULL
mg/ml	NULL
!	NULL
)	NULL

,	NULL
5	NULL
ug	NULL
protein	NULL
extract	NULL
and	NULL
0.2-1	NULL
ng	NULL
radioactively	NULL
labelled	NULL
DNA	NULL
.	NULL

After	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
min	NULL
,	NULL
the	NULL
reaction	NULL
products	NULL
were	NULL
separated	NULL
in	NULL
a	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

In	NULL
competition	NULL
and	NULL
supershift	NULL
experiments	NULL
either	NULL
unlabelled	NULL
oligonucleotide	NULL
or	NULL
1	NULL
1	NULL
tissue	NULL
culture	NULL
supernatant	NULL
containing	NULL
monoclonal	NULL
antibody	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
mixture	NULL
.	NULL

The	NULL
following	NULL
were	NULL
used	NULL
as	NULL
anti-EBNA2	NULL
monoclonal	NULL
antibodies	NULL
:	NULL
R1	NULL
(	NULL
rat	NULL
IgG1	NULL
)	NULL
,	NULL
174	NULL
R2	NULL
(	NULL
rat	NULL
IgG2a	NULL
)	NULL
,	NULL
R3	NULL
(	NULL
rat	NULL
IgG2a	NULL
)	NULL
and	NULL
R11	NULL
(	NULL
rat	NULL
IgG2a	NULL
)	NULL
.	NULL

R1	NULL
and	NULL
R3	NULL
recognize	NULL
EBNA2A	NULL
with	NULL
the	NULL
same	NULL
affinity	NULL
as	NULL
EBNA2B	NULL
,	NULL
whereas	NULL
R2	NULL
and	NULL
R11	NULL
recognize	NULL
EBNA2A	NULL
,	NULL
but	NULL
have	NULL
a	NULL
very	NULL
low	NULL
affinity	NULL
(	NULL
R2	NULL
)	NULL
or	NULL
no	NULL
affinity	NULL
(	NULL
R11	NULL
)	NULL
to	NULL
EBNA2B	NULL
.	NULL

Anti-mouse	NULL
CD45	NULL
(	NULL
rat	NULL
IgG1	NULL
or	NULL
rat	NULL
IgG2a	NULL
)	NULL
were	NULL
used	NULL
as	NULL
isotypic	NULL
control	NULL
antibodies	NULL
.	NULL

In	NULL
vitro	NULL
translation	NULL
pGa206/6	NULL
was	NULL
digested	NULL
with	NULL
Nael	NULL
.	NULL

The	NULL
4.5	NULL
kb	NULL
fragment	NULL
containing	NULL
the	NULL
EBNAZ	NULL
ORF	NULL
and	NULL
regulatory	NULL
sequences	NULL
was	NULL
prepared	NULL
and	NULL
transcribed	NULL
using	NULL
T3	NULL
RNA	NULL
polymerase	NULL
and	NULL
a	NULL
Boehringer	NULL
in	NULL
vitro	NULL
transcription	NULL
kit	NULL
.	NULL

The	NULL
resultant	NULL
RNA	NULL
was	NULL
translated	NULL
in	NULL
vitro	NULL
using	NULL
a	NULL
Promega	NULL
reticulocyte	NULL
lysate	NULL
translation	NULL
kit	NULL
.	NULL

The	NULL
translation	NULL
products	NULL
were	NULL
assayed	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
Western	NULL
blotting	NULL
.	NULL

Radioactively	NULL
labelled	NULL
probes	NULL
pTP1-CAT/-543	NULL
was	NULL
digested	NULL
with	NULL
Nrul	NULL
and	NULL
HindIII	NULL
.	NULL

The	NULL
isolated	NULL
fragment	NULL
was	NULL
labelled	NULL
with	NULL
Klenow	NULL
polymerase	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
32P	NULL
]	NULL
dCTP	NULL
.	NULL

The	NULL
©54bp	NULL
was	NULL
synthesized	NULL
with	NULL
5'-protruding	NULL
ends	NULL
,	NULL
which	NULL
were	NULL
filled	NULL
in	NULL
with	NULL
Klenow	NULL
polymerase	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Acknowledgements	NULL
We	NULL
thank	NULL
W.Hammerschmidt	NULL
for	NULL
providing	NULL
the	NULL
p6O4	NULL
plasmid	NULL
and	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
and	NULL
B.Kempkes	NULL
for	NULL
providing	NULL
the	NULL
plasmid	NULL
pBSmutC	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Die	NULL
Deutsche	NULL
Forschungsgemein-schaft	NULL
(	NULL
Forschergruppe	NULL
Virus-Zellwechselwirkung	NULL
)	NULL
and	NULL
Fonds	NULL
der	NULL
Chemischen	NULL
Industrie	NULL
.	NULL

References	NULL
Abbot	NULL
,	NULL
S.D	NULL
.	NULL

,	NULL
Rowe	NULL
,	NULL
M.	NULL
,	NULL
Cadwallader	NULL
,	NULL
K.	NULL
,	NULL
Ricksten	NULL
,	NULL
A.	NULL
,	NULL
Gordon	NULL
,	NULL
J.	NULL
,	NULL
Wang	NULL
,	NULL
F.	NULL
,	NULL
Rymo	NULL
,	NULL
L	NULL
.	NULL

and	NULL
Rickinson	NULL
,	NULL
A.B	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
64	NULL
,	NULL
2126-2134	NULL
.	NULL

Adldinger	NULL
,	NULL
H.K	NULL
.	NULL

,	NULL
Delius	NULL
,	NULL
H.	NULL
,	NULL
Freese	NULL
,	NULL
U.K.	NULL
,	NULL
Clarke	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Bormkamm	NULL
,	NULL
G	NULL
.	NULL

W.	NULL
(	NULL
1985	NULL
)	NULL
Virology	NULL
,	NULL
141	NULL
,	NULL
221-234	NULL
.	NULL

Baer	NULL
,	NULL
R	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Nature	NULL
,	NULL
310	NULL
,	NULL
207-211	NULL
.	NULL

Bornkamm	NULL
,	NULL
G	NULL
.	NULL

W.	NULL
,	NULL
Hudewentz	NULL
,	NULL
J.	NULL
,	NULL
Freese	NULL
,	NULL
U.K.	NULL
and	NULL
Zimber	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
43	NULL
,	NULL
952-968	NULL
.	NULL

Calender	NULL
,	NULL
A.	NULL
,	NULL
Billaud	NULL
,	NULL
M.	NULL
,	NULL
Aubry	NULL
,	NULL
J.P.	NULL
,	NULL
Banchereau	NULL
,	NULL
J.	NULL
,	NULL
Vuillaume	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Lenoir	NULL
,	NULL
G.M	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
84	NULL
,	NULL
8060-8064	NULL
.	NULL

Cann	NULL
,	NULL
A.J	NULL
.	NULL

,	NULL
Koyanagi	NULL
,	NULL
J.	NULL
,	NULL
Chen	NULL
,	NULL
LS.Y	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Oncogene	NULL
,	NULL
3	NULL
,	NULL
123-128	NULL
.	NULL

Cohen	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Kieff	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
65	NULL
,	NULL
5880-5885	NULL
.	NULL

Cohen	NULL
,	NULL
J.I	NULL
.	NULL

,	NULL
Wang	NULL
,	NULL
F.	NULL
,	NULL
Mannick	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Kieff	NULL
,	NULL
E.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
86	NULL
,	NULL
9558-9562	NULL
.	NULL

Collins	NULL
,	NULL
$	NULL
.J	NULL
.	NULL

,	NULL
Ruscetti	NULL
,	NULL
F	NULL
.	NULL

W.	NULL
,	NULL
Gallagher	NULL
,	NULL
R.E	NULL
.	NULL

and	NULL
Gallo	NULL
,	NULL
R.C	NULL
.	NULL

(	NULL
1978	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
75	NULL
,	NULL
2458-2462	NULL
.	NULL

Cordier	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
64	NULL
,	NULL
1002-1013	NULL
.	NULL

Crawford	NULL
,	NULL
D.H.	NULL
,	NULL
Epstein	NULL
M.A	NULL
.	NULL

,	NULL
Bornkamm	NULL
,	NULL
G	NULL
.	NULL

W.	NULL
,	NULL
Achong	NULL
,	NULL
B.G	NULL
.	NULL

,	NULL
Finerty	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Thompson	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
,	NULL
24	NULL
,	NULL
294-302	NULL
.	NULL

Dambaugh	NULL
,	NULL
T	NULL
.	NULL

,	NULL
Hennessy	NULL
,	NULL
K.	NULL
,	NULL
Chamnankit	NULL
,	NULL
L	NULL
.	NULL

and	NULL
Kieff	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
81	NULL
,	NULL
7632-7636	NULL
.	NULL

Dignam	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
Lebovitz	NULL
,	NULL
R.M	NULL
.	NULL

and	NULL
Roeder	NULL
,	NULL
R.G	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
11	NULL
,	NULL
1475-1489	NULL
.	NULL

Fahraeus	NULL
,	NULL
R.	NULL
,	NULL
Jansson	NULL
,	NULL
A.	NULL
,	NULL
Ricksten	NULL
,	NULL
A.	NULL
,	NULL
Sjoblom	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Rymo	NULL
,	NULL
L	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
87	NULL
,	NULL
7390-7394	NULL
.	NULL

Ghosh	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
18	NULL
,	NULL
1749-1756	NULL
.	NULL

Ghosh	NULL
,	NULL
D	NULL
and	NULL
Kieff	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
64	NULL
,	NULL
1855-1858	NULL
.	NULL

Grasser	NULL
,	NULL
F	NULL
.	NULL

A.	NULL
,	NULL
Haiss	NULL
,	NULL
P.	NULL
,	NULL
Gottel	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Miiller-Lantzsch	NULL
,	NULL
N	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
65	NULL
,	NULL
3779-3788	NULL
.	NULL

Hammerschmidt	NULL
,	NULL
W.	NULL
and	NULL
Sugden	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Nature	NULL
,	NULL
340	NULL
,	NULL
393-397	NULL
.	NULL

Hinuma	NULL
,	NULL
Y.	NULL
,	NULL
Konn	NULL
,	NULL
M.	NULL
,	NULL
Yamaguchi	NULL
,	NULL
J.	NULL
,	NULL
Wudarski	NULL
,	NULL
D.J	NULL
.	NULL

,	NULL
Blakeslee	NULL
,	NULL
J.R.J	NULL
.	NULL

and	NULL
Grace	NULL
,	NULL
J.T.J	NULL
.	NULL

(	NULL
1967	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
1	NULL
,	NULL
1045-1051	NULL
.	NULL

Jeang	NULL
,	NULL
K.T	NULL
.	NULL

and	NULL
Hayward	NULL
,	NULL
S8.D	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
48	NULL
,	NULL
135-148	NULL
.	NULL

Jin	NULL
,	NULL
X.W	NULL
.	NULL

and	NULL
Speck	NULL
,	NULL
S.H	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
66	NULL
,	NULL
2846-2852	NULL
.	NULL

Kieff	NULL
,	NULL
E	NULL
.	NULL

and	NULL
Licbowitz	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
In	NULL
Fields	NULL
,	NULL
B	NULL
.	NULL

and	NULL
Knipe	NULL
,	NULL
D.	NULL
(	NULL
eds	NULL
)	NULL
,	NULL
Virology	NULL
.	NULL

Raven	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
,	NULL
pp	NULL
.	NULL

1889-1920	NULL
.	NULL

Knutson	NULL
,	NULL
J.C	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
64	NULL
,	NULL
2530-2536	NULL
.	NULL

Laux	NULL
,	NULL
G.	NULL
,	NULL
Perricaudet	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Farrell	NULL
,	NULL
P.J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
7	NULL
,	NULL
769-774	NULL
.	NULL

Lenoir	NULL
,	NULL
G.M	NULL
.	NULL

,	NULL
Vuillaume	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Bonnardel	NULL
,	NULL
C	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
IARC	NULL
Sci	NULL
.	NULL

Publ	NULL
.	NULL

,	NULL
60	NULL
,	NULL
309-318	NULL
.	NULL

Lillie	NULL
,	NULL
J.W	NULL
.	NULL

and	NULL
Green	NULL
,	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
,	NULL
338	NULL
,	NULL
39-44	NULL
.	NULL

Lindahl	NULL
,	NULL
T.	NULL
,	NULL
Adams	NULL
,	NULL
A.	NULL
,	NULL
Bjursell	NULL
,	NULL
G.	NULL
,	NULL
Bornkamm	NULL
,	NULL
G	NULL
.	NULL

W.	NULL
,	NULL
Kaschka-Dierich	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Jehn	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1976	NULL
)	NULL
J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
102	NULL
,	NULL
511-530	NULL
.	NULL

Liu	NULL
,	NULL
F	NULL
.	NULL

and	NULL
Green	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
,	NULL
61	NULL
,	NULL
1217-1224	NULL
.	NULL

Miller	NULL
,	NULL
G.	NULL
,	NULL
Robinson	NULL
,	NULL
J.	NULL
,	NULL
Heston	NULL
,	NULL
L.	NULL
and	NULL
Lipman	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1974	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
USA	NULL
,	NULL
71	NULL
,	NULL
4006-4010	NULL
.	NULL

Polack	NULL
,	NULL
A.	NULL
,	NULL
Hartl	NULL
,	NULL
G.	NULL
,	NULL
Zimber	NULL
,	NULL
U.	NULL
,	NULL
Freese	NULL
,	NULL
U.K.	NULL
,	NULL
Laux	NULL
,	NULL
G.	NULL
,	NULL
Takaki	NULL
,	NULL
K.	NULL
,	NULL
Hohn	NULL
,	NULL
B.	NULL
,	NULL
Gissmann	NULL
,	NULL
L	NULL
.	NULL

and	NULL
Bormnkamm	NULL
,	NULL
G	NULL
.	NULL

W.	NULL
(	NULL
1984	NULL
)	NULL
Gene	NULL
,	NULL
27	NULL
,	NULL
279-288	NULL
.	NULL

Puivertaft	NULL
,	NULL
R.J.V	NULL
.	NULL

(	NULL
1964	NULL
)	NULL
Lancet	NULL
,	NULL
1	NULL
,	NULL
238-240	NULL
.	NULL

Rickinson	NULL
,	NULL
A.B	NULL
.	NULL

,	NULL
Young	NULL
,	NULL
L.S	NULL
.	NULL

and	NULL
Rowe	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
61	NULL
,	NULL
1310-1317	NULL
.	NULL

Sample	NULL
,	NULL
J.	NULL
,	NULL
Liebowitz	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Kieff	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
63	NULL
,	NULL
933-937	NULL
.	NULL

Stern	NULL
,	NULL
$	NULL
.	NULL

,	NULL
Tanaka	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Herr	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
,	NULL
341	NULL
,	NULL
624-630	NULL
.	NULL

Sung	NULL
,	NULL
N.S	NULL
$	NULL
.	NULL

,	NULL
Kenney	NULL
,	NULL
$	NULL
S.	NULL
,	NULL
Gutsch	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Pagano	NULL
,	NULL
J.S	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
65	NULL
,	NULL
6765-6771	NULL
.	NULL

Tsang.S.F	NULL
.	NULL

,	NULL
Wang	NULL
,	NULL
F.	NULL
,	NULL
Kenneth	NULL
,	NULL
M.1	NULL
.	NULL

and	NULL
Kieff	NULL
,	NULL
E.	NULL
(	NULL
1991	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
65	NULL
,	NULL
6765-6771	NULL
.	NULL

Wang	NULL
,	NULL
F.	NULL
,	NULL
Gregory	NULL
,	NULL
C.D	NULL
.	NULL

,	NULL
Rowe	NULL
,	NULL
M.	NULL
,	NULL
Rickinson	NULL
,	NULL
A.B	NULL
.	NULL

,	NULL
Wang	NULL
,	NULL
.D	NULL
.	NULL

,	NULL
Birkenbach	NULL
,	NULL
M.	NULL
,	NULL
Kikutani	NULL
,	NULL
H.	NULL
,	NULL
Kishimoto	NULL
,	NULL
T.	NULL
and	NULL
Kieff	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
84	NULL
,	NULL
3452-3456	NULL
.	NULL

Wang	NULL
,	NULL
F.	NULL
,	NULL
Hitoshi.K	NULL
.	NULL

,	NULL
Tsang	NULL
,	NULL
S.F	NULL
.	NULL

,	NULL
Kishimoto	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Kieff	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
65	NULL
,	NULL
4101-4106	NULL
.	NULL

Westin	NULL
,	NULL
G.	NULL
,	NULL
Gerster	NULL
,	NULL
T	NULL
.	NULL

,	NULL
Miiller	NULL
,	NULL
M.M	NULL
.	NULL

,	NULL
Schaffner	NULL
,	NULL
G	NULL
.	NULL

and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1987	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
15	NULL
,	NULL
6787-6789	NULL
.	NULL

Woisetschlaeger	NULL
,	NULL
M.	NULL
,	NULL
Jin	NULL
,	NULL
X.W	NULL
.	NULL

,	NULL
Yandava	NULL
,	NULL
C.N	NULL
.	NULL

,	NULL
Furmanski	NULL
,	NULL
L.A.	NULL
,	NULL
Strominger	NULL
,	NULL
J.L	NULL
.	NULL

and	NULL
Speck	NULL
,	NULL
S.H	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
88	NULL
,	NULL
3942-3946	NULL
.	NULL

Zimber	NULL
,	NULL
U	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Virology	NULL
,	NULL
154	NULL
,	NULL
56-66	NULL
.	NULL

Zimber-Strobl	NULL
,	NULL
U.	NULL
,	NULL
Suentzenich	NULL
,	NULL
K.0	NULL
.	NULL

,	NULL
Laux	NULL
,	NULL
G.	NULL
,	NULL
Eick	NULL
,	NULL
D.	NULL
,	NULL
Cordier	NULL
,	NULL
M.	NULL
,	NULL
Calender	NULL
,	NULL
A.	NULL
,	NULL
Billaud	NULL
,	NULL
M.	NULL
,	NULL
Lenoir	NULL
,	NULL
G	NULL
.	NULL

M.	NULL
and	NULL
Bornkamm	NULL
,	NULL
G	NULL
.	NULL

W.	NULL
(	NULL
1991	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
65	NULL
,	NULL
415-423	NULL
.	NULL

Received	NULL
on	NULL
July	NULL
20	NULL
,	NULL
1992	NULL
;	NULL
revised	NULL
on	NULL
September	NULL
10	NULL
,	NULL
1992	NULL
EBNA2Z	NULL
interaction	NULL
with	NULL
TP1	NULL
promoter	NULL
175	NULL

